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resumo 
 
 
Peroxissomas são organelos celulares de membrana simples, os quais têm 
importantes funções metabólicas, como por exemplo metabolismo de lípidos e ROS, 
sendo assim indispensáveis para a saúde e desenvolvimento humano. Os 
peroxissomas são organelos altamente flexíveis e dinâmicos que rapidamente se 
agregam, multiplicam e degradam em resposta a necessidades metabólicas. Em 
cultura celular, o stress oxidativo e outros estímulos externos (ex. factores de 
crescimento, ácidos gordos, despolimerização) têm mostrado induzir processos de 
crescimento (alongamento) e divisão de peroxissomas, os quais estão relacionados 
com a sua proliferação. Considerando que alguns dos componentes moleculares da 
maquinaria de crescimento e divisão têm sido identificados nos últimos anos, as vias 
de sinalização e regulação que medeiam a proliferação de peroxissomas são 
largamente desconhecidas.  
O objectivo desta dissertação de mestrado foi examinar o efeito de diferentes 
estímulos externos promotores de ROS na indução do crescimento/proliferação do 
compartimento peroxisomal. Foi seleccionado um sistema de cultura de células de 
mamífero que apresentam um compartimento peroxisomal dinâmico. Análises 
baseadas em fluorescência para a detecção da produção de ROS e alterações nos 
níveis de GSH intracelular foram estabelecidos. Estes procedimentos foram usados 
primeiro para esclarecer se o alongamento de peroxissomas observado após 
despolimerização de microtubulos (pelo nocodazole) é mediado por ROS. O 
alongamento de peroxissomas e a despolimerização dos microtubulos após 
tratamento com nocodazole foi monitorizado e quantificado por microscopia de 
imunofluorescência. O Nocodazole induziu um aumento dos níveis de ROS intracelular 
e apesar do pré tratamento com antioxidantes ter baixado os níveis de ROS, não 
preveniu o alongamento peroxisomal. Estes resultados demonstram que as alterações 
morfológicas do compartimento peroxisomal induzidas pelo nocodazole são 
independentes da produção de ROS. Para além disso, foi examinado o efeito de 
alterações nos níveis de glutationa (GSH) celular no compartimento peroxisomal. 
Interessantemente, a redução dos níveis de GSH intracelular pelo BSO, um inibidor da 
enzima γ-glutamylcystein synthetase (γ-GCS), resultou num aumento acentuado de 
crescimento/proliferação de peroxissomas. Os níveis de ROS e GSH foram 
determinados por análises baseadas em fluorescência. Pré tratamento com 
antioxidante preveniu o alongamento de peroxissomas indicando que a alteração no 
estado redox celular (citoplasmatico) levou à proliferação de peroxissomas a qual 
exerce, supostamente, uma função protectora para a célula. Finalmente, foi 
investigado se a inibição da cadeia respiratória mitocondrial e com isso, se ROS 
provenientes das mitocondrias foi capaz de induzir crescimento e divisão dos 
peroxissomas. Entre os inibidores analisados, apenas a rotenona, inibidor do 
complexo I, teve um efeito proeminente na elongação de peroxissomas. Todavia, foi 
demontrado que o seu efeito é devido à acção que a rotenona tem na 
despolimerização dos microtubulos. Assim, apesar da relação de proximidade entre 
mitocondria e peroxissomas, as ROS provenientes das mitocondrias não são prováveis 
de induzir alterações no compartimento peroxisomal. Os nossos resultados também 
indicam que estudos in vivo usando a rotenona têm de ser interpretados com muito 
cuidado. Além disso, os resultados mostram que as ROS podem alterar a dinâmica do 
compartimento peroxissomal, mas têm de vir de locais específicos dentro da célula 
(por exemplo, do citosol).  
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abstract 
 
Peroxisomes are single membrane bound subcellular organelles, which fulfill 
important metabolic functions, for example in lipid and ROS metabolism, and are thus 
indispensable for human health and development. Peroxisomes are highly flexible 
organelles that rapidly assemble, multiply and degrade in response to metabolic 
needs. In cultured cells, oxidative stress and other external stimuli (e. g. growth 
factors, fatty acids, microtubule depolymerization) have been shown to induce 
processes of growth (elongation) and division of peroxisomes, which are related to 
peroxisome proliferation. Whereas some of the molecular components of the growth 
and division machinery have been identified in the last years, the regulatory and 
signaling pathways mediating peroxisome proliferation are largely unknown. 
The aim of this master thesis was to examine the effects of different ROS-producing 
external stimuli on the induction of growth/proliferation of the peroxisomal 
compartment. A suitable mammalian cell culture system with a dynamic peroxisomal 
compartment was selected and fluorescent-based assays for the detection of ROS 
production and changes in the intracellular GSH levels were established. The setup 
was first used to clarify if peroxisome elongation observed after depolymerization of 
microtubules (by nocodazole) is mediated by ROS. Peroxisome elongation and 
microtubule depolymerization after nocodazole treatment was monitored and 
quantified by immunofluorescence microscopy. Although nocodazole induced an 
increase in cellular ROS levels, a pre-treatment with antioxidants and lowering of 
intracellular ROS levels did not prevent peroxisome elongation. These findings 
demonstrate that the morphological changes of the peroxisomal compartment 
induced by nocodazole are independent of ROS production. Furthermore, I examined 
the effect of changes in the cellular redox state on the peroxisomal compartment. 
Interestingly, the reduction of intracellular GSH levels by BSO, an inhibitor of γ-
glutamylcystein synthetase (γ-GCS), resulted in a prominent increase in peroxisomal 
growth/elongation. ROS and GSH levels were determined by fluorescent-based 
assays. Pre-treatment with antioxidants prevented peroxisome elongation indicating 
that changes in the cellular (cytoplasmic) redox state lead to peroxisome proliferation, 
which is supposed to have a protective function for the cell. Finally, I investigated 
whether inhibition of the mitochondrial respiratory chain and thus, mitochondria-
derived ROS were capable of inducing peroxisomal growth and division. Among the 
inhibitors tested, only rotenone, a complex I inhibitor, had a prominent effect on 
peroxisome elongation. However, I demonstrated that this effect is due to a 
microtubule-depolymerizing activity of rotenone. Thus, despite the close peroxisome-
mitochondria relationship, mitochondria-derived ROS are unlikely to induce changes 
of the peroxisomal compartment. Our findings also indicate that in vivo studies using 
rotenone have to be interpreted with great care. In addition, the results show that 
ROS can alter the dynamics of the peroxisomal compartment, but have to come from 
specific locations (e.g. the cytosol) within the cell.  
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I. INTRODUCTION 
1. PEROXISOMES 
1.1. GENERAL FEATURES 
 Peroxisomes (originally called microbodies) were discovered in 1954 using 
electron microscopy in mouse kidney (Rhodin, 1954). De Duve and  Baudhuin (1966) were 
the first who isolated peroxisomes from rat liver, and their biochemical studies led to the 
discovery of the colocalization of several H2O2-producing oxidases as well as catalase, an 
H2O2-degrading enzyme, in the matrix of peroxisomes (see Chapter I. 1.2., Figure 2). On 
the basis of these findings, De Duve proposed the functional term “peroxisome”, which 
gradually replaced the former morphological designation, “microbody”, coined by Rhodin, 
(1954). A specific cytochemical staining for peroxisomes in light and electron microscopy 
became available with the introduction of the alkaline 3, 3’-diaminobenzidine (DAB) 
reaction for catalase (Fahimi, 1968; Novikoff and Goldfischer, 1969) (Figure 1). 
Subsequent morphological studies exploiting this cytochemical procedure revealed that 
peroxisomes, such as mitochondria, are ubiquitous eukaryotic organelles (Hruban et al., 
1972). 
 
 
Figure 1. (A) Cytochemical localization of catalase in rat hepatic peroxisomes stained with the alkaline diamine-benzidine technique 
(Fahimi, 1969). Note the uniform staining of the peroxisome matrix. Magnification, x 28,600 (from Schrader and Fahimi, 2008).  
Electron micrographs of peroxisomes from regenerating rat liver. (B-C) Sections were stained cytochemically for localization of catalase 
(Fahimi, 1969). (B) A peroxisome with an elongated tail-like extension. Magnification, x 65,000. (C) A tubular peroxisome next to a 
lysosome (LYS) and in close association with endoplasmic reticulum (ER), Magnification, x 85,000 (Schrader and Fahimi, 2006a).  
 
 Peroxisomes are morphologically characterized by a single limiting membrane 
surrounding a fine granular matrix, which may contain crystalline inclusions of matrix 
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enzymes, with a range in size from 0.1-1 µm in diameter. Peroxisomes display some 
variability in morphology, enzyme content and metabolic function. Thus, they are 
designated as “multi-purpose organelles”. Peroxisomes are adjusted according to cellular 
needs (Opperdoes, 1988) and vary among different species, developmental stages and 
organs, even within the same organisms (Schrader and Fahimi, 2006a). They show a 
pronounced morphological plasticity, with highly dynamic structures exhibiting rapid 
changes of their shape, number and intracellular distribution. This plasticity is dependent 
on the organism, cell type and prevailing environmental conditions (Platta and Erdmann, 
2007b; Schrader et al., 1998a). 
 Since peroxisomes are devoid of DNA, all peroxisomal proteins are encoded by the 
nuclear genome and have to be imported post-translationally into peroxisomes. More 
than 60 yeast and 80 human genes encoding peroxisomal proteins have been identified. 
Many of them are metabolic enzymes, necessary for their crucial role in cellular 
metabolism, such as β-oxidation of fatty acids and H2O2 detoxification (see Chapter I. 
1.2.). Another group of peroxisomal proteins, called peroxins, is required for the 
biogenesis and maintenance of functional peroxisomes (see Chapter I. 2.) (reviewed in 
Schrader and Fahimi, 2008).  
 
1.2. PEROXISOMAL FUNCTIONS 
 Notwithstanding the simplicity of peroxisome morphology, these organelles show 
a broad functional diversity.  
 The β-oxidation of fatty acids and the detoxification of the hydrogen peroxide 
produced are the central functions of peroxisomes. In fungi and plants the fatty acid 
degradation pathway is exclusively localized in the peroxisomal compartment, whereas in 
mammalian cells the breakdown of different types of fatty acids is distributed between 
peroxisomes and mitochondria (Platta and Erdmann, 2007a; Schrader and Yoon, 2007) 
(see Chapter I. 4.2.).   
 The massive proliferation of peroxisomes in the livers of rats treated with the 
hypolipidemic drug clofibrate (see Chapter I. 6.1.) (Hess et al., 1965) was the first 
indication of the possible involvement of peroxisomes in lipid metabolism and led 
eventually to the discovery of fatty acid β-oxidation in animal cells (Lazarow and De Duve, 
1976). Other functions of peroxisomes include the biosynthesis of cholesterol, bile acids 
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and ether lipids (e.g. plasmalogens) which comprise more than 80% of the phospholipid 
content of white matter in the brain (Wanders and Waterham, 2006b; Platta and 
Erdmann, 2007a), catabolism of amino acids, polyamines and purines, detoxification of 
xenobiotics, glyoxylate, and last but not least reactive oxygen species (ROS) (see Chapter 
I. 5.) (Schrader and Fahimi, 2008; Delille et al., 2006). The metabolic pathways of 
peroxisomes are illustrated in Figure 2.   
 
 
 
Figure 2. The major metabolic pathways in peroxisomes of the mammalian liver. The very long chain fatty acids 
(VLCFA) are transported by membrane proteins (e.g., the ABC transporter proteins PMP70 or ALDP) into the matrix, 
where they are oxidized by the lipid β-oxidation enzymes. The products of the β-oxidation can either serve as substrates 
for the biosynthesis of ether glycerolipids, cholesterol and bile acids or may exit the peroxisome for further oxidation in 
mitochondria (MITO). Peroxisomal β-oxidation and the activity of other peroxisomal oxidases result in the production of 
hydrogen peroxide, which is decomposed by catalase. Asterisks, there are separate enzymes for bile acid intermediates, 
sER smooth endoplasmic reticulum, ALDP adrenoleukodystrophy protein (Schrader and Fahimi, 2008). 
 
 
 
 
 
 
Introduction
Mestrado em Métodos Biomoleculares
12 
 
1.3. IMPORTANCE OF PEROXISOMES 
 The critical role of peroxisomes in a variety of metabolic processes, especially in 
lipid metabolism, renders them essential for human health and development (Delille et 
al., 2006). Furthermore, their importance is also emphasized by the existence of inherited 
disorders that are caused by peroxisomal dysfunction (Wanders and Waterham, 2005; 
Steinberg et al., 2006). 
 As peroxisomes are central eukaryotic organelles, disturbances of their function 
can lead to severe multisystem pathologies, often associated with neurological and 
developmental defects. Inherited peroxisomal disorders can be divided into two main 
subgroups: the peroxisomal biogenesis disorders (PBDs) and the more frequent 
peroxisomal (single) enzyme deficiencies (PEDs) (see Chapter I. 5.3.) (Wanders and 
Waterham, 2006a). 
 
2. BIOGENESIS OF PEROXISOMES 
 Peroxisomes are devoid of DNA or a protein translation machinery, and all of their 
proteins are encoded by nuclear genes. Most of the peroxisomal proteins (peroxisomal 
membrane and matrix proteins) are synthesized on free polyribosomes in the cytoplasm 
and are then post-translationally directed to the organelle (Lazarow and Fujiki, 1985). 
 The biogenesis of peroxisomes is thought to begin with the formation of the 
peroxisomal membrane – which involves both recruitment of lipids as well as the 
targeting and insertion of membrane proteins into the lipid bilayer – and is followed by 
targeting and import of peroxisomal matrix proteins to form a metabolically functional 
organelle. Subsequently, peroxisomes can grow and proliferate until the organelle is 
finally degraded (Lazarow and Fujiki, 1985). 
 
2.1. IMPORT OF PEROXISOMAL MATRIX PROTEINS 
 Sorting of peroxisomal matrix proteins is achieved by cytosolic receptors (Pex5p 
for PTS1 and Pex7p for PTS2) that recognize two well-characterized classes of peroxisomal 
targeting signals (PTS1 and PTS2). The PTS1 comprises a C-terminal tripeptide (SKL), 
whereas the PTS2 is located near the N-terminus (Ma and Subramani, 2009). Most of the 
identified peroxins are involved in matrix protein import and contribute to the formation 
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of the docking and translocation machinery at the peroxisomal membrane. It is assumed 
that the receptors accompany their cargo inside the peroxisomes and recycle back to the 
cytosol (Platta and Erdmann, 2007a). In contrast to proteins imported into mitochondria 
or endoplasmic reticulum (ER), peroxisomal proteins pass through the intact peroxisomal 
membrane in a folded or even oligomeric state. For a review on peroxisomal import see 
Gould and Collins, 2002; Eckert and Erdmann, 2003; Ma and Subramani, 2009. 
 
2.2. IMPORT OF PEROXISOMAL MEMBRANE PROTEINS 
 The insertion of peroxisomal membrane proteins (PMPs) requires the peroxins 
Pex19p, Pex3p and Pex16p. It is suggested that Pex19p functions as a cycling 
receptor/chaperone for PMPs, which is recruited to the peroxisomes by the membrane 
receptor Pex3p (Ma and Subramani, 2009). This is based on the finding that most PMPs 
contain conserved Pex19p-binding sites which almost always are also required for their 
peroxisomal localization and protein stability (Vizeacoumar et al., 2006; Rottensteiner et 
al., 2004). Most PMPs contain a peroxisomal membrane targeting signal (mPTS) that is 
recognized by the import receptor and chaperon Pex19p which directs its cargo to the 
peroxisomal membrane or alternatively to the ER during de novo formation of 
peroxisomes (see Chapter I. 3.1.) (Platta and Erdmann, 2007b). 
 
3. PEROXISOME FORMATION 
3.1. GROWTH AND DIVISION VS. ER MATURATION 
 Peroxisome formation, multiplication/proliferation and maintenance have been 
debated for a long time, and is still in discussion. According to the classical view, 
peroxisomes represent autonomous organelles, which form out of pre-existing 
peroxisomes by growth and division (Lazarow and Fujiki, 1985). 
 The “growth and division” model was supported by the discovery of the synthesis 
of peroxisomal proteins on free ribosomes, their post-translational transport into 
peroxisomes, and the observation of interconnections between peroxisomes. 
Furthermore, peroxisomes have been reported to divide, and recently proteins of the 
peroxisomal division machinery have been identified in yeast, mammalian and plant cells 
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(Fagarasanu et al., 2007; Schrader and Fahimi, 2006b). In contrast, the ER-maturation 
concept proposes that the ER contributes to peroxisome formation (Tabak et al., 2006). 
The degree of this contribution is, however, controversially discussed, whereas there is 
general agreement that the ER provides the lipids for the formation of the peroxisomal 
membrane. Its role in the delivery of peroxisomal membrane proteins (PMPs) is hotly 
debated (Delille et al., 2009). 
 The ER-maturation-model received strong support by the observation that a loss 
of the peroxins Pex3p, Pex16p, or Pex19p, which are required for peroxisomal membrane 
biogenesis and PMP targeting/insertion (Van Ael and Fransen, 2006) (see Chapter I. 2.2.) 
resulted in the absence of detectable peroxisomes/peroxisomal membranes, whereas 
their reintroduction led to a de novo formation of peroxisomes from the ER. The Pex3p 
and Pex19p have been observed to initially localize to the ER before maturing into import-
competent peroxisomes (Ma and Subramani, 2009), indicating that the ER is the source of 
the newly synthesized membrane and organelle. However, recent findings in S. cerevisiae 
indicate that in wild-type cells, peroxisomes multiply by growth and division and do not 
form de novo. Only cells lacking peroxisomes as a result of a segregation defect were 
observed to form peroxisomes de novo out of the ER (Motley and Hettema, 2007; Nagotu 
et al., 2008b). Furthermore, evidence has been presented that Pex3p is directly 
transported to peroxisomes in a novel Pex19p- and Pex16p-dependent manner in 
mammalian cells (Matsuzaki and Fujiki, 2008). Thus, the physiological significance of the 
mechanism of de novo formation in comparison to the classical pathway of growth and 
division is debatable. The de novo formation of peroxisomes from the ER may represent a 
rescue mechanism that becomes functional in some organisms only in case peroxisomes 
are lost (e.g., due to failure in inheritance) (Delille et al., 2009). 
 
3.2. GROWTH AND DIVISION OF PEROXISOMES 
 Morphological observations show that growth and division of peroxisomes in 
mammalian cells is a multistep process including peroxisome elongation (Chapter I. 5.), 
constriction, and final fission (reviewed in Schrader 2006; Schrader and Fahimi, 2008). 
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Figure 3. Schematic view of peroxisome dynamics and interactions in mammalian cells. Most peroxisomal (and 
mitochondrial) matrix and membrane proteins (class I PMPs) are synthesized on free polyribosomes in the cytosol and 
are posttranslationally imported into pre-existing organelles. Other membrane proteins (class II PMPs, early peroxins; 
e.g., Pex3p) are routed to peroxisomes via the ER or a pre-peroxisomal compartment, presumably by vesicular 
transport. A retrograde peroxisome-to-ER transport might also exist. A novel vesicular mitochondria-to-peroxisome 
trafficking route has been described recently (Neuspiel et al., 2008). A well defined sequence of morphological changes 
of peroxisomes, including elongation (growth), constriction, and final fission (division) contributes to peroxisome 
proliferation in mammalian cells. Pex11βp is involved in the elongation (tubulation) of peroxisomes, whereas DLP1 and 
Fis1 mediate peroxisomal (and mitochondrial) fission. Fis1 is supposed to recruit cytosolic DLP1 to the peroxisomal 
(mitochondrial) membrane. The involvement of other components (related to yeast Mdv1p/Caf4p) is likely. Mff, which 
localizes to mitochondria and peroxisomes, might be involved in constriction. Proper intracellular distribution of 
peroxisomes formed by fission requires microtubules (MT) and motor proteins. In yeast and plants peroxisomes are 
distributed via the actin cytoskeleton (Schrader and Fahimi, 2008). Organelle dynamics are supposed to be linked to 
degradation by autophagy (pexophagy, mitophagy) (from Camoes et al, 2009). 
 
 Pex11 proteins are implicated early in the elongation step of peroxisome division, 
whereas dynamin-related proteins (DRPs), and Fis1 catalyze the final fission event 
(Schrader and Fahimi, 2006a, 2008). In mammals, three Pex11p isoforms, designated 
Pex11α, Pex11β, and Pex11γ, have been identified. They are all integral PMPs and have 
both their amino and carboxyl termini exposed to the cytosol. A striking increase in 
elongated forms of peroxisomes upon expression of Pex11p has been observed in all 
organisms studied, indicating that tubule formation is an important aspect of peroxisome 
division (Schrader et al., 1996b, 1998b). 
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 In mammals, the dynamin-related GTPase DLP1 (dynamin like protein) has been 
reported to be essential for peroxisome division presumably by forming ring-like 
structures around the membrane constrictions, thus regulating the final fission step in a 
nucleotide-dependent manner. Fis1, a protein targeted to both the peroxisomal and 
mitochondrial membrane, has been shown to function as a DLP1 adaptor protein (Koch et 
al., 2005). Recently, a second mammalian adaptor protein, mitochondrial fission factor 
(Mff) was reported to control mitochondrial and peroxisomal fission (Gandre-Babbe and 
van der Bliek, 2008; Delille et al., 2009). Interestingly, Fis1, Mff and DLP1 are also involved 
in mitochondrial fission and are shared by both organelles (see Chapter I. 4., Figure 5) 
(Schrader, 2006; Delille et al., 2009). 
 
3.3. PEROXISOMES AND THE CYTOSKELETON  
 The cytoskeleton plays an essential role in intracellular translocation, distribution 
and determination of the shape of membrane-bounded organelles. The generation and 
maintenance of this organization is particularly dependent on the microtubular system. 
The importance of microtubular interactions has been demonstrated for numerous 
organelles including peroxisomes (Schrader et al., 2003; Thiemann et al., 2000).  
 Several studies with microtubule-active drugs, like nocodazole, colcemid and 
vinblastine - and also with the microtubule-stabilizing drug paclitaxel (taxol) - have been 
performed to investigate the interaction of the cytoskeleton and in particular the 
microtubule system with the peroxisomal compartment. Depolymerization of 
microtubules by nocodazole disrupted the intracellular organization and fast transport of 
the peroxisomal compartment (Wiemer et al., 1997; Schrader et al., 1996b; Schrader et 
al., 2003). Treatment with nocodazole resulted in the formation of large peroxisomal 
clusters indicating that microtubules are required for the proper distribution of 
peroxisomes throughout the cytoplasm (Schrader et al., 1996a; Wiemer et al., 1997).  
 Interestingly, microtubules are not essential for the formation, maintenance and 
dynamics of tubular or reticular peroxisomes (Schrader et al., 1996a; Schrader et al., 
1998a; Schrader et al., 2000). Tubular peroxisomes can be formed in the complete 
absence of microtubules (Schrader et al., 1998a) and, surprisingly, tubule formation in 
HepG2 cells is induced by microtubule depolymerising agents (Schrader et al., 1996a). 
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This is quite different from other organelles with tubular or reticular shapes such as 
mitochondria (Johnson et al., 1980) or lysosomes (Swanson et al., 1987), which collapse 
or fragment after microtubule-depolymerisation. Furthermore, it seems unlikely that 
microtubules are involved in the formation of new peroxisomes by budding or fission out 
of a pre-existing compartment, e.g., during peroxisome proliferation, since the 
segmentation of tubular peroxisomes has been observed to be microtubule-independent 
(Schrader et al., 1996a; Schrader et al., 1998a).  
 
4. THE PEROXISOME – MITOCHONDRIA CONNECTION  
 It has become more obvious over the last years that peroxisomes do not exist as 
single, isolated organelles, but that they co-operate extensively with other organelles, 
especially with mitochondria (Schrader and Yoon, 2007; Camoes et al., 2009). 
 Interestingly, several findings indicate that, despite obvious differences, 
mitochondria and peroxisomes share certain morphological and functional similarities 
(Figure 5). Both organelles can adopt a variety of different shapes in eukaryotic cells, 
ranging from small, spherical compartments to tubulo-reticular networks. Peroxisomes 
and mitochondria also share components of their division machinery (see Chapter I. 3.1. 
and I. 4.1., Table 1, Figure 4). Both organelles cooperate in the β-oxidation of fatty acids 
(see Chapter I. 4.2., Figure 5) and contribute to the metabolism of reactive oxygen species 
(see Chapter I. 5.4.). These observations indicate that peroxisomes and mitochondria 
exhibit a much closer interrelationship than previously assumed, which is supposed to 
have an impact on their cooperative functionality and contribution to diseases (Camoes 
et al., 2009). 
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4.1. SHARED COMPONENTS OF PEROXISOMAL AND 
MITOCHONDRIAL DIVISION 
 As already mentioned (see Chapter I. 3.1.), some of the fission factors (e.g. 
DLP1/Drp1, Fis1, Mff) are shared between mitochondria and peroxisomes (Table 1) 
(Camoes et al., 2009; Schrader, 2006). The targeting of Fis1 to peroxisomal and 
mitochondrial membranes seems to follow independent mechanisms, but there might be 
a competition between mitochondria and peroxisomes for DRP1 and its membrane 
anchor Fis1 (Table 1, Figure 4) (Delille and Schrader, 2008). Mff is another shared 
component of mitochondrial and peroxisomal fission in mammalian cells (Table 1, Figure 
4) (Gandre-Babbe and van der Bliek, 2008; Delille et al., 2009). In yeast, the soluble 
adaptors Mdv1 and Caf4 are involved in recruiting Dnm1 to peroxisomes and 
mitochondria for fission (Motley et al., 2008; Nagotu et al., 2008a). Sharing components 
of the division machinery between peroxisomes and mitochondria appears to be an 
evolutionary conserved strategy across organisms (Table 1). 
 As the basic fission machinery is shared by mitochondria and peroxisomes 
(Schrader and Fahimi, 2006a, 2008), dysfunction of the components is likely to affect both 
organelles and to lead to combined diseases. The first case of a division defect in 
peroxisomes and mitochondria has been described recently (Waterham et al., 2007). 
Genetic analysis revealed a missense mutation in the central domain of DLP1 in a patient 
who died only few weeks after birth. Skin fibroblasts from the patient displayed 
elongated peroxisomes and mitochondria indicative for a block in DLP1-dependent 
organelle fission. The patient showed microcephaly, abnormal brain development, optic 
atrophy and hypoplasia. The important role of DLP1 in embryonic and brain development 
in mice has recently been demonstrated by the generation of DLP1 knock-out mice 
(Ishihara et al., 2009; Wakabayashi et al., 2009). Peroxisomes and mitochondria in these 
mice displayed an elongated or clustered morphology. 
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 Table 1. Shared components of the peroxisomal and mitochondrial division machinery across organisms 
et al., 2009).  
Plants 
Peroxisomes Mitochondria Peroxisomes
Fis1a, b  Fis1a, b  Fis1 
  
? ELM1 Mdv1 Caf4
DRP3A, B  DRP3A, B  
DRP1C, E 
ADL2 
Dnm1 
Vps1
Pex11  
(a-e)  Pex11 
 
a) Identified in A. thaliana (Arimura et al., 2008)
cerevisae but not in H. polymorpha.
Figure 4. Organelle division in mammals. 
GTPase performing the final scission of constricted membranes and is recruited from the cytosol by the tail
protein hFis1, which might regulate organelle morphology and fission through self
interact with the peroxin Pex11β, which is known to regulate peroxisomal abundance and to tubulate membranes. 
is a novel tail-anchored protein involved in peroxisomal and mitochondrial division. It is supposed to function in a 
complex different from hFis1. In yeast, add
in mitochondrial and peroxisomal division (see Table 1)
 
4.2. PEROXISOMAL AND MITOCHONDRIAL METABOLISM AND 
CROSS-TALK 
 In animal cells, mitochondria and 
systems which are distributed between the two organelles
peroxisomes and mitochondria contain their own sets of individual β
DLP1
Pex11β
Mff
Peroxisomes
Yeast Mammals 
 Mitochondria Peroxisomes Mitochondria
 Fis1  hFis1  hFis1  
- - Mff  Mff  
 
2
  
Mdv1  
Caf42  ? ? 
 
3
 
Dnm1  Drp1/DLP1 
 
Drp1/DLP1 
 
 
Mmm1, 2 
Mdm (10, 12, 
31-33) 
Pex11  
(α,β,γ)  
; b) Only present in S. cerevisae and C. glabrata
 
Peroxisomes and mitochondria are divided by similar machineries. 
-interaction. hFis1 is supposed to 
itional linker proteins (Mdv1, Caf4) have been identified which are involved 
 (from Delille et al., 2009). 
peroxisomes have separate
 (Figure 5)
-oxidation enzymes, 
hFis1
DLP1
hFis1Mff
Mitochondria
19 
(from Delille 
  
 Family Function 
TA protein 
TPR motif 
Membrane 
adapter 
protein 
TA protein 
Membrane 
adapter 
protein? 
WD protein 
other 
Cytosolic 
linker 
protein 
large 
GTPase 
Final 
scission 
 
Membrane 
tubulation 
; c) Required in S. 
 
DLP1 is a 
-anchored 
Mff 
d β-oxidation 
. Although 
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 which differ in molecular and catalytic 
identical and involves the same reaction steps
double bond), (3) dehydrogenation, and (4) thiolytic cleavage 
al., 2006).  
 Both peroxisomes and mitochondria have different substrate specificities and 
consequently different functions in their β
importance for β-oxidation because they catabolize
that cannot be handled by mitochondria and thus prevent the toxic effects caused by 
accumulation of these compounds (e.
However, peroxisomes are unable to oxidize fatty acids to completion
shortened fatty acids are shuttled to the mitochondria for full oxidation 
(Wanders, 2004; Schrader and Yoon, 2007)
biogenesis of both organelles.
Figure 5. An overall representation of peroxisomal
outer membrane; MIM, mitochondrial inner membrane; MOM, mitochondrial outer membrane; TCA, tricarboxylic acid; 
AA, amino acid; ROS, reactive oxygen species; VLCFA, very long
medium chain fatty acids; β-OX, fatty acid beta
(from Schrader and Yoon, 2007). 
properties, the mechanism of β
: (1) dehydrogenation, (2) hydration (of the 
(Wanders, 2004
-oxidation systems. Peroxisomes have a great 
 a variety of fatty acids and derivatives 
g. very long chain fatty acids, phytanic acid). 
. This requires a coordinated cross
 
 and mitochondrial cooperation and cross
 chain fatty acids; LCFA, long
-oxidation; CAT, catalase; RC, respiratory chain; ATPsyn,
20 
-oxidation is 
; Poirier et 
, and the chain-
(Figure 5) 
-talk and 
 
-talk. POM, peroxisomal 
-chain fatty acids; MCFA, 
 ATP synthetase 
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 Furthermore, both mitochondria and peroxisomes have a key role in both the 
production and scavenging of reactive oxygen species (ROS) (Schrader and Yoon, 2007), 
which will be discussed later (see Chapter I. 5.4.). 
 
5. PEROXISOMES AND OXIDATIVE STRESS 
5.1. OXIDATIVE STRESS 
 Reactive oxygen species (ROS) are formed and degraded by all aerobic organisms, 
leading to either physiological concentrations required for normal cell function, or 
excessive quantities, a state called oxidative stress (Nordberg and Arner, 2001). Oxidative 
stress takes place when the net flux of free radical production exceeds the antioxidant 
defenses of the cell (Bonekamp et al., 2009). Oxidative stress can be induced by various 
stressors like environmental toxins, ionizing and UV irradiation, heat shock or 
inflammation, all conditions in which the balance between generation and scavenging of 
ROS is disturbed. The resulting damage within the cells is based on the fact that the ROS 
increase leads on the one hand to a deregulation of redox sensitive pathways, and on the 
other hand to oxidative modification of all essential biomolecules (e.g. DNA, proteins, 
lipids) (Bonekamp et al., 2009). These hallmarks of oxidative stress are linked to many 
pathological conditions such as ischemia-reperfusion injury, atherosclerosis, 
hypertension, type-2 diabetes, cancer and neurodegenerative diseases (Schrader and 
Fahimi, 2006b). Besides their harmful role in pathological conditions, the importance of 
ROS and reactive nitrogen species (RNS) as mediators in various vital cellular processes 
and cell signaling pathways has became clear like their role in apoptosis, for example 
(Droge, 2003; Saran, 2003).  
 
5.2. PEROXISOMES AND REACTIVE OXYGEN SPECIES 
 ROS include a number of chemically reactive molecules derived from oxygen, 
containing free (unpaired) electrons, such as the superoxide radical anion (O2 
•-
), the 
hydroxyl radical (HO
•
), and peroxyl radicals (ROO•), as well as nonradical derivatives of 
molecular oxygen (O2), such as hydrogen peroxide (H2O2), hypochlorous acid (HOCl), 
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singlet oxygen O2 and peroxynitrite (ONOO
_
) (Fridovich, 1999; Betteridge, 2000; Jezek and 
Hlavata, 2005). Although H2O2 per se does not contain any unpaired electrons, it is 
ascribed to ROS, as it can be easily converted into more aggressive radical species, for 
example into HO• via Fenton-catalyzed reduction. Moreover, H2O2 is membrane 
permeable and diffusible, proving it suitable for intracellular signalling (Bonekamp et al., 
2009). 
 Peroxisomes are one of the main sites in the cell where oxygen free radicals are 
both generated and scavenged. Initially, it was assumed that the main function of 
peroxisomes was the decomposition of H2O2 generated by different peroxisomal oxidases 
(mainly flavoproteins) via catalase, the classical peroxisomal marker enzyme (Figure 6). 
However, it is now clear that peroxisomes are involved in a variety of important cellular 
functions in almost all eukaryotic cells. The main metabolic processes contributing to the 
generation of H2O2 in peroxisomes are the β-oxidation of fatty acids, the enzymatic 
reactions of the flavin oxidases, the disproportion of superoxide radicals, and in plant 
peroxisomes, the photorespiratory glycolate oxidase reaction (Schrader and Fahimi, 
2006b). 
 The oxidation of the various substrates is performed by O2
-
-consuming oxidases 
that produce H2O2 as a by-product which is then decomposed by catalase and other 
resident antioxidant enzymes (Figure 6). Moreover, RNS are also produced within 
peroxisomes, as the inducible form of nitric oxide synthase (NOS, Figure 6) which 
catalyses the oxidation of L-arginine to nitric oxide (
•
NO) has been detected at 
peroxisomes (Stolz et al., 2002). Oxidative stimuli appear to be linked to ‘‘growth and 
division’’-based peroxisome proliferation (see Chapter I. 3.1.), in which peroxisomes 
undergo a well-defined sequence of morphological changes, including elongation 
(growth), constriction and final fission (division) (see Chapters I. 3. and I. 6., Figure 3). 
 The extent to which peroxisomes are key players in oxidative metabolism is 
exemplified by the fact that they consume 20% of the total amount of oxygen consumed 
while producing 35% of all the cells H2O2 (Boveris et al., 1972). Thus, oxidative balance 
within peroxisomes needs to be tightly regulated - shifting this exact balance via endo- or 
exogenous factors, ageing or disease conditions leads to a deregulation of the system 
(Bonekamp et al., 2009). 
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Figure 6. Schematic overview of peroxisomal ROS homeostasis. The various peroxisomal metabolites (e.g. VLCFA) are 
transported across the membrane via specific transporters (e.g. ABCD1), while most peroxisomal matrix proteins are 
imported in a PTS1/Pex5p-dependent manner. Substrates are then broken down by peroxisomal oxidases (light purple) 
which transfer the hydrogen extracted from the substrate directly to O2. The generated H2O2 is subsequently converted 
to H2O and O2 by peroxisomal antioxidant enzymes (light blue), with catalase being the most prominent one. An 
additional by-product of xanthine oxidase (XOx) activity is O
•-
2 which is scavenged by manganese superoxide dismutase 
(MnSOD) and copper-zinc-superoxide dismutase (CuZnSOD). Mpv17 and M-LP (dark blue) are implicated in the 
regulation of peroxisomal ROS metabolism, but their peroxisomal localization has been questioned. Nitric oxide 
synthase (NOS, dark purple) catalyses the oxidation of L-arginine to nitric oxide (
•
NO), which can react with O
•-
2 radicals 
to form peroxynitrite (ONOO
-
), a powerful oxidant. Both H2O2 and 
•
NO can pass the peroxisomal membrane and act in 
cellular signalling. PTS1, peroxisomal targeting signal 1; VLCFA, very long chain fatty acids; D-AAOx, D-amino acid 
oxidase; UOx, urate oxidase; ACOx, acyl-CoA oxidase; XOx, xanthine oxidase; NOS, nitric oxide synthase; GPx, 
glutathione peroxidase; Prx: peroxiredoxin; M-LP, Mpv17-like protein (from Bonekamp et al., 2009). 
  
 To degrade the ROS, which are produced due to their metabolic activity, and to 
maintain the equilibrium between production and scavenging of ROS, peroxisomes 
harbor several powerful defense mechanisms and antioxidant enzymes in addition to 
catalase (Schrader and Fahimi, 2006b) (Figure 6 and Table 2). Although peroxisomes are 
considered a source of oxidative stress due to their oxidative metabolism, they respond 
to oxidative stress and ROS, which have been generated in other intra- or extracellular 
locations (e.g. in mitochondria, see Chapter I. 5.3.), most likely to protect the cell against 
an oxidative damage. Furthermore, certain peroxisome-generated ROS may act as 
mediators in intracellular signalling (Masters, 1996). 
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Table 2. Overview of ROS/RNS generated in mammalian peroxisomes (PO) (from Bonekamp et al., 2009). NOHLA, Nx-
hydroxy-L-arginine. 
 
 
5.3. PEROXISOMAL DISORDERS AND ROS 
 Inherited peroxisomal disorders can be divided into two main subgroups: the 
peroxisomal biogenesis disorders (PBDs) and the more frequent peroxisomal (single) 
enzyme deficiencies (PEDs) (see Chapter I. 1.3.) (Wanders and Waterham, 2006a). One of 
the most prominent PEDs, the X-linked adrenoleukodystrophy (X-ALD), caused by 
mutations in the ABCD1 gene that encodes the transporter of VLCFA and/or its CoA-
derivatives (Figure 7) (van Roermund et al., 2008), is a fatal neurodegenerative disorder 
(Wanders and Waterham, 2006a). It is characterized by an accumulation of VLCFAs, 
progressive demyelination/neurodegeration in the central nervous system and adrenal 
insufficiency. It was surmised that the accumulated VLCFAs could either incorporate into 
complex lipids and destabilize them (Moser et al., 2001) or that they could increase 
oxidative stress and lead to oxidative modification in nervous tissue (Schonfeld and 
Reiser, 2006), both possibilities inducing demyelination (Bonekamp et al., 2009). 
 Fourcade et al. (2008) have recently investigated the relation between oxidative 
lesions and neurodegeneration in an ABCD1 knock-out model, although the mouse model 
rather reproduces a milder AMN (adreno myelo neuropathy) phenotype of ALD. They also 
demonstrated that the VLCFA C26:0 accumulation could be a cause of oxidative stress via 
mild inhibition of the mitochondrial electron transfer chain (ETC), and also compromised 
Introduction
Mestrado em Métodos Biomoleculares
25 
 
cellular GSH levels, thus combining to result in oxidative lesions that probably play a 
crucial role in neurodegeneration, as nervous tissue is very susceptible to oxidative 
damage (Arlt et al., 2002) (Figure 7 B, top). Another example of oxidative stress in 
peroxisomal disorders is observed in patients suffering from Zellweger syndrome as well 
as those with an enzyme defect in the bile acid synthesis pathway (Figure 7 B, bottom). 
 
5.4. PEROXISOMES, MITOCHONDRIA AND ROS METABOLISM 
 Mitochondria and peroxisomes have a key role in both the production and 
scavenging of reactive oxygen species (ROS) (Schrader and Yoon, 2007). The 
mitochondrial electron transport chain is a major site of free radical generation. The 
major formation of superoxide radicals occurs at complex I (NADH-coQ reductase) and 
complex III (cytochrome bc1 complex) (Figure 9). In peroxisomes, the numerous oxidases 
along with cytochrome B5, a cytochrome P-450-dependent hydroxylation system, produce 
ROS including hydrogen peroxide, superoxide radicals and hydroxyl radicals (Figure 6, 7; 
Table 2) (Schrader and Fahimi, 2006b). 
 Both peroxisomes and mitochondria contain antioxidant systems to minimize 
oxidative damage. Peroxisomes contain multiple antioxidant enzymes: catalase, Cu-Zn-
SOD, glutathione peroxidase, MnSOD, epoxide hydrolase, PMP20 and peroxiredoxin (I, V, 
VI) (Figure 6). Mitochondria contain antioxidant molecules (glutathione, NADH, 
thioredoxin) and enzymes that degrade ROS (MnSOD, glutathione reductase, glutathione 
peroxidase) (Schrader and Yoon, 2007). Under conditions of oxidative stress, where the 
mitochondria generate more H2O2 than under normal conditions, the glutathione 
peroxidase/glutathione reductase system is often limited by the level of glutathione (and 
NADPH), and is inefficient in decomposing the increased H2O2. The H2O2 that escapes 
across the mitochondrial membrane might be degraded by catalase in the peroxisome (or 
in the cytosol) (Figure 5) (Schrader and Yoon, 2007). ROS accumulation, itself a 
consequence of defects in mitochondrial or peroxisomal function, will also affect 
mitochondrial morphology and function (see Chapter I. 4.). Another possibility is that 
retrograde signaling through transcriptional regulators might affect mitochondria and 
peroxisomes. Regulators such as PPARα (see Chapter I. 6.1.) might induce changes in 
mitochondria by feedback regulation if peroxisomes are defective (Thoms et al., 2009). 
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 It is suggested that both mitochondrial and peroxisomal dysfunction and ROS 
generation contribute to ageing (Figure 7 A) neurodegeneration and carcinogenesis 
(Moldovan and Moldovan, 2004; Schrader and Fahimi, 2006b; Beal, 2005). 
 
Figure 7. (A) Schematic overview of age-related alterations in peroxisomal ROS homeostasis and its putative 
consequences. With advancing age, the homeostatic balance of pro- and antioxidants is upset. Enzyme levels are 
altered and the fidelity of the PTS1/Pex5p-dependent import system is compromised. Catalase in particular is reduced 
or lost, leading to an accumulation of H2O2 in the organelle. H2O2 can subsequently be converted into the very reactive 
•OH radical by metal-ion catalyzed Fenton chemistry which then modifies peroxisomal proteins and lipids. Moreover, 
H2O2 can diffuse across the membrane into the cytoplasm where it perturbs regular ROS signalling, reacts into more 
damaging ROS and modifies essential biomolecules such as proteins and DNA, leading to cell damage. In addition, H2O2 
also affects the PTS1/Pex5p import system, thereby further compromising catalase levels in peroxisomes, resulting in a 
negative feedback. Compromised catalase and the consequently elevated H2O2 also contributes to age-related 
mitochondrial dysfunction, as it decreases mitochondrial membrane potential and leads to the production of 
mitochondrial ROS, further elevating cellular ROS levels and oxidative damage. (B) Schematic overview of the effects of 
certain peroxisomal diseases on ROS homeostasis. (Top) In X-linked adrenoleukodystrophy, the function of the ABCD1 
membrane transporter is compromised, leading to an accumulation of its substrates, VLCFA, in the cytoplasm. It was 
shown that the VLCFA C26:0 has a mild inhibitory effect on the mitochondrial electron transfer chain (ETC) while 
glutathione (GSH) levels are also compromised. Both factors combine, leading to ROS increase inside the cells and 
oxidative lesions. (Bottom) C27-bile acids accumulate under certain pathological conditions such as Zellweger syndrome 
or single enzyme deficiencies associated with bile acid synthesis. It was recently shown that they are potent inhibitors 
of the mitochondrial electron transfer chain, leading to an increase in ROS production that leads to harmful oxidative 
damage. Additionally, depending on their levels, C27 bile acids can either induce apoptosis or necrosis (from Bonekamp 
et al., 2009). 
 
 Additionally, impairment of normal peroxisomal function in for example, X-ALD or 
Zellweger syndrome leads to an accumulation of substrates (e.g. VLCFA, bile acids 
intermediates) that also directly have an effect on mitochondria and their redox balance 
by inhibiting the electron transfer chain (Figure 7 B). A pathophysiological link between 
the organelles can also be deduced from the fact that mitochondria in Pex5
-/-
 mice show 
an extremely altered morphology with marked abnormalities in various tissues (Schrader 
and Fahimi, 2006b; Baumgart et al., 2001). Several authors described reduced oxidative 
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capacities of mitochondria in liver, brain and muscle tissue of PBD patients (Thoms et al., 
2009). 
 Disturbance of mitochondrial β-oxidation leads to a shift in peroxisomal β-
oxidation which results in an increase in ROS production due to higher activity of 
peroxisomal oxidases, inducing oxidative lesions in hepatic tissue. Mitochondrial 
dysfunction was further shown to exert an effect on peroxisome abundance in yeast. 
Screening for peroxisome-morphology mutants in S. cerevisiae revealed that many 
mutants in mitochondrial genes display increased peroxisome number compared to 
controls (Motley et al., 2008). 
 
6. SIGNALLING AND PEROXISOME ELONGATION  
6.1. PEROXISOME PROLIFERATION 
 The plasticity of peroxisomes to undergo proliferation in response to a variety of 
intrinsic and extrinsic stimuli has been quite well-known and used for the investigation of 
diverse questions such as the biogenesis of this organelle and its biochemical 
characterization (Fahimi et al., 1982). The list of compounds inducing proliferation of 
peroxisomes in rodent liver is very long comprising divergent drugs, industrial chemicals 
such as lubricants and plasticizers, as well as agrochemicals (Schrader and Fahimi, 2006a). 
Peroxisome proliferation in mammals is regulated by nuclear transcription 
factors which belong to the superfamily of steroid/thyroid/retinoid receptors and were 
originally designated as peroxisome proliferator activated receptors (PPARs) (Issemann 
and Green, 1990). Three subtypes of PPARs were identified in different species: α, β and 
γ. The PPARs form heterodimers with retinoid X receptors (RXRs) and bind to specific 
DNA-sequences known as peroxisome proliferator response elements (PPREs) initiating 
the transcription of responsive genes (Figure 8). PPREs have been reported not only for all 
peroxisomal lipid β-oxidation enzymes but also for several microsomal cytochrome P-450 
subtypes as well as for apolipoproteins type I and II (Schoonjans et al., 1996). 
 Peroxisome proliferation in mammalian cells appears to be initiated by 
extracellular signals, such as signals mimicked by peroxisome proliferators, which by 
activating intracellular signalling cascades, lead to the activation of the transcription 
factors PPARα and PPARγ. These have been shown to induce the transcription of 
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PEX11pα (Li et al., 2002). As activation of PPARα affects numerous metabolic pathways 
(Reddy and Hashimoto, 2001), and as metabolic activities have also been shown to affect 
the number of peroxisomes (Chang et al., 1999, Funato et al., 2005), this peroxisome 
proliferation pathway might be mediated through some kind of metabolic control. 
Although the activation of PEX11p is a common theme in the course of peroxisome 
proliferation, yeasts, plants and mammals have evolved distinct upstream mechanisms to 
actualize this process (Figure 8) (Kaur and Hu, 2009). 
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 Figure 8. Comparative model for the activation of PEX11 genes in yeast, mammals and plants. 
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appear to act directly on the peroxisomal membrane, the other conditions require 
intracellular signalling to induce peroxisome elongation/growth (Schrader et al., 1998a). 
Arachidonic acid, for example, is a substrate for peroxisomal β-oxidation, but has also 
been shown to stimulate ROS production by cultured cells (Dymkowska et al., 2006). In 
plant cells (but also in mammals) it is suggested that diverse types of stress (e. g. 
wounding, pathogen attack, drought, osmotic stress, excess light) that generate H2O2 as a 
signalling molecule result in peroxisome proliferation via the up-regulation of PEX genes 
required for peroxisome biogenesis and import of proteins (del Rio et al., 2002; Lopez-
Huertas et al., 2000; Desikan et al., 2001). A striking increase in elongated forms of 
peroxisomes upon expression of Pex11p has been observed in all organisms studied 
(Schrader et al., 1998b, Thoms and Erdmann, 2005). 
 In cultured cells, oxidative stress has been shown to induce morphological changes 
of the peroxisomal compartment. In mammalian and plant cells a pronounced elongation 
of peroxisomes is observed after UV irradiation, direct exposure to H2O2, or even during 
live cell imaging of GFP-PTS1 labeled peroxisomes by regular fluorescent microscopy 
(Schrader et al., 1999; Schrader and Fahimi, 2004, 2006b). Antioxidant treatment blocked 
the elongation of peroxisomes, thus supporting the role of ROS in UV-mediated 
peroxisomal growth (Schrader et al., 1999). Very recently, the rapid dynamic formation of 
peroxisomal tubular extensions in plant cells after exposure to H2O2 has been reported 
(Sinclair et al., 2009). Formation of these extensions was later on followed by peroxisome 
elongation and division, suggesting the existence of a rapid, transcription independent 
pathway and a transcription-dependent pathway in peroxisome response to H2O2 
/oxidative stress. 
However, most of the UV- or ROS-mediated signalling pathways and the gene 
responses leading to peroxisome elongation/proliferation are still largely unknown. 
Although information on the exact functions of elongated/tubular or complex 
peroxisomal structures is scarce, the evidence of ROS-mediated peroxisome 
elongation/proliferation and induction of peroxisomal genes supports an involvement in 
cellular rescue from ROS.  
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II. AIMS  
Peroxisomes are crucial subcellular compartments for human life and health (Schrader 
and Fahimi, 2008). They orchestrate important functions during development, and 
peroxisome proliferation as well as dysfunctions are linked to tumor formation, 
neurodegeneration and aging. Previous work from our laboratory has demonstrated that 
different external stimuli (including UV-irradiation and ROS production) induce 
morphological alterations of the peroxisomal compartment, which are linked to 
peroxisome proliferation (Schrader et al., 1999, Schrader and Fahimi, 2004,  2006b). 
These alterations are supposed to exert a protective function, and are therefore 
important for the role of peroxisomes in health and disease. Furthermore, our group 
presented evidence that peroxisomes and mitochondria exhibit a much closer 
interrelationship than previously assumed (Camoes et al., 2009). 
The general aim of the present study was to investigate if cellular manipulations which 
lead to the intracellular production of ROS (e.g. via mitochondrial respiration) are capable 
of inducing growth/proliferation of the peroxisomal compartment. As little is known 
about the ROS-mediated signalling pathways and the gene responses regulating 
peroxisomal biogenesis and disease, further insights are of great importance. 
SPECIFIC AIMS 
1. Selection and development of a mammalian cell culture system to examine 
peroxisomal growth/proliferation induced by different stressors. 
2. Establishing fluorescent-based assays to measure and quantify ROS production and 
changes in the redox state of the cell. 
3. Examination of the effect of different stressors on the induction of peroxisomal 
growth/proliferation in mammalian cells. Among them cytoskeleton-active drugs, 
inhibitors of the mitochondrial respiratory chain and compounds affecting the redox 
state of the cell were tested. Alterations of the peroxisomal compartment were 
visualized and quantified by immunofluorescence microscopy. 
4. Involvement of ROS in peroxisomal growth/proliferation. ROS and GSH levels were 
measured and treatments with antioxidants were performed to verify the 
involvement of ROS. 
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MATERIALS 
1. ANTIBODIES 
Table 3. List of antibodies used in this work 
 Antigen IMF Species Supplier Reference 
Primary 
antibodies 
PMP70  1:100 
Rabbit (polyclonal 
antibody) 
kindly provided by A. 
Völkl, University of 
Heidelberg, Germany 
 
 
Schrader et 
al., 1998b 
PEX14 
 
1:200 
Rabbit (polyclonal 
antibody) 
kindly provided by D. 
Crane, Griffith 
University, Brisbane 
Australia 
 
 
Nguyen et 
al., 2006 
α tubulin  1:100 
Mouse 
(monoclonal 
antibody) 
BD Biosciences 
Pharmingen, San 
Diego, CA, USA 
 
 
Boll and 
Schrader, 
2005  
TOM20  1:200 
Mouse 
(monoclonal 
antibody) 
 
BD Biosciences, USA 
 
Wang et al., 
2009 
 
α acetylated 
tubulin  
1:100 
Mouse 
(monoclonal 
antibody) 
 
Sigma-Aldrich, 
Deisenhofen, 
Germany  
 
Shim et al., 
2008 
      
Secondary 
antibodies 
DαRb-Alexa 
488 
1:400 Donkey 
Dianova (Hamburg, 
Germany) 
 
 
Delille and 
Schrader, 
2008 
DαM-TRITC 1:100 Donkey 
Dianova (Hamburg, 
Germany) 
Delille and 
Schrader, 
2008 
 
 IMF: Indirect Immunofluorescence  
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2. CHEMICAL COMPOUNDS 
Table 4. List of the chemical compounds used to treat the cells in this work 
Drugs Description Supplier References 
Nocodazole 
Microtubule 
depolymerizing drug 
Sigma-Aldrich 
 
Schrader et al., 
1996a, 1998a, 
2000 
 
 
L-Buthionine - 
Sulfoximine 
GSH depletion 
kindly provided by J.  
Jordán (Centro 
Universidad de 
Castilla La Mancha, 
Albacete, Spain) 
Sigma-Aldrich  
 
 
Jordan et al., 2002, 
Fernandez-Gomez et 
al., 2005, Neely et al., 
2005 
 
 
Rotenone 
Complex I inhibitor of the 
mitochondrial respiratory 
chain  
kindly provided by J. 
Jordán  
(Sigma-Aldrich) 
 
Srivastava and 
Panda, 2007, Ren and 
Feng, 2007 
Sodium Azide 
Complex IV inhibitor of 
mitochondrial respiratory 
chain  
 
Sigma-Aldrich  
Gomez-Nino et al., 
2009 
 
    
Antioxidants Description Supplier References 
N-acetyl cysteine 
Low molecular weight 
antioxidant, precursor of 
glutathione 
 
Sigma-Aldrich  
Schrader et al., 1999, 
Bowes and Gupta, 
2005 
 
Vitamin C 
Low molecular weight 
antioxidant 
 
Sigma-Aldrich 
 
Gomez-Lazaro et al., 
2008 
 
Vitamin E 
Low molecular weight 
antioxidant 
 
Sigma-Aldrich Jordan et al., 2000 
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3. LIST OF EQUIPMENT 
 
 Vertical laminar flow hood  – Heraeus, Germany  
 CO2 incubator  – Sanyo, Japan  
 Centrifuge  –  5810R  Eppendorf , Germany 
 Inverted microscope  –  Leica DMIL, Leitz, Wetzlar, Germany 
 Fluorescence microscope – Olympus IX81 microscope (Olympus Optical, Germany) 
equipped with a PlanApo 100X / 1.40 objective 
 Nitrogen tank  –  Cryomed Forma Scientific, USA  
 pH Meter, Sartorius, Germany 
 Analytical balance, Sartorius BP 221S, Germany 
 Thermal Cycler (mixing and incubation of samples) - Thermomixer 5436, 
Eppendorf, Germany 
 Water bath – Memmert, Germany 
 Electromagnetic agitator – Agimatic-N (JP Selecta), Vidrolab, Spain 
 Multifunctional microplate reader TECAN i-control – infinite 200, Austria GmbH  
 Spectophotometer – Perkin-Elmer fluorometer (luminescence-spectrophotometer 
LS50B), Perkin-Elmer, Wellesley, USA  
 Autoclave – Uniclave 88, Portugal 
 Sterilizing oven  –  Sanyo Drying Oven, Leicestershire, UK  
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4. LIST OF BUFFERS AND REAGENTS 
 
Phosphate Buffered Saline (PBS) 10x, pH 7.4 
1.37 M NaCl; 26.8 mM KCl; 78.1 mM Na2HPO4 (2 H2O2); 14.7 mM KH2PO4  
Krebs buffer, pH 7.4 
140 mM NaCl; 5.9 mM KCl; 1.2 mM MgCl2; 15 mM HEPES; 10 mM glucose; 2.5 mM CaCl2 
Trypsin/EDTA solution  
Trypsin/EDTA 0.05% / 0.02% in Dulbecco's-PBS (PAA Laboratories GmbH, Pashing, Austria) 
Cell Culture Medium 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 2 g/liter sodium 
bicarbonate, 2 mM glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 10% fetal 
calf serum (FCS) (all from PAA Laboratories GmbH, Pashing, Austria) 
Freezing medium (DMEM) 
20% FCS and add 10% DMSO to preserve the cells. Filtrate to sterilize.  
4% para-Formaldehyde (w/v), pH 7.4 for immunofluorescence 
Weigh 4 g pFA, add 90 ml H2O, 1N NaOH. Shake and heat no more than 60ºC, remove 
from heat. Then add 10 ml 1xPBS and adjust pH to 7.4, store at -20ºC  
0.2% Triton-X-100 (v/v), pH 7.4 for immunofluorescence 
0.5 ml Triton-X-100, adjust to 250 ml with 1x PBS 
2% BSA (w/v) for immunofluorescence, pH 7.4 
Weigh 1 g BSA and adjust to 50 ml with 1xPBS 
n-propyl-Gallat for immunofluorescence  
Weigh 0.625 g n-propyl-Gallate add 12 ml 1xPBS (adjust pH to 7.0) add 12.5 ml glycerol, 
stir overnight (in the dark). Store at 4ºC in a dark bottle 
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Mowiol (mounting solution for fluorescence microscopy)  
Weigh 10 g Mowiol 4-88 add 40 ml 1xPBS (stir overnight) and 20 ml Glycerol (ultrapure) 
(stir overnight). Then centrifuge 1h, 1500 rpm (Centrifuge Eppendorf 5810R), take 
supernatant, add NaN3 and store at 4ºC.  
Use, 3 parts Mowiol (stock) + 1 part n-propyl-Gallate 
Dimethyl Sulfoxide (DMSO) – 99. 9%  
Oxidation-sensitive fluorescent dye 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-
DA) 
Stock solution prepared in DMSO at 10 mM, and used at 10 µM in 1x PBS  
Monochlorobimane (mBCL) fluorescent  
Stock solution prepared in DMSO at 80 mM, and used at 160 µM in Krebs buffer 
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METHODS 
 
1. CELL CULTURE 
 
1.1. CELL LINES 
 
 At the beginning of this study, different mammalian cell lines have been tested by 
immunofluorescence microscopy (see Methods, Chapter 3.) to select a cell culture model 
with an elaborate and dynamic peroxisomal compartment suitable to monitor 
peroxisome elongation and proliferation. In addition, serum-containing and serum-free 
culture conditions were tested to select optimal conditions for induction of ROS and 
stimulation of peroxisome elongation/proliferation (not shown). 
 The following cell lines have been tested: 
HepG2 cells are well differentiated human hepatocellular carcinoma cells 
(hepatoblastoma). This cell line was obtained from the American Type Culture Collection 
(ATCC; Rockville, MD) (ATCC number: HB - 8065). 
 COS-7 cells are derived from kidney epithelial cells of the African green monkey. 
The line was derived from the CV-1 cell line (ATCC® CCL-70) by transformation with an 
origin defective mutant of SV40 which codes for wild type T antigen. SV40 is an 
abbreviation for Simian vacuolating virus 40 or Simian virus 40, a polyomavirus that is 
found in both monkeys and humans (http://www.lgcstandards-atcc.org). COS-7 cells were 
obtained from the American Type Culture Collection (ATCC; Rockville, MD) (ATCC number: 
CRL-1651).   
COS-7-GFP-PTS1 cells are derived from COS-7 cells by stable transfection with a 
construct encoding for a fusion protein of green fluorescent protein (GFP) carrying a 
peroxisomal targeting signal 1 (PTS1). The three amino acids added (SKL; serine-lysine-
leucine) represent a consensus peroxisomal targeting sequence (PTS1), which is sufficient 
to direct a polypeptide to peroxisomes in vivo in animals, plants, and yeasts.  
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 Although HepG2 cells exhibit several morphologically distinct forms of 
peroxisomes, and COS-7-GFP-PTS1 cells have the advantage not to require antibody 
based staining of peroxisomes, we decided to use COS-7 cells for most of the experiments 
performed. COS-7 cells showed a prominent response to the stressors applied, as well as 
good cell viability and cell growth. In addition, morphological changes of the peroxisomal 
compartment (e.g. elongation; see IV, Figure 12 B.) were readily visible and easy to 
quantitate.  
 
1.2. CELL CULTURE MAINTENANCE 
 
The cells were routinely cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 2 g/liter sodium bicarbonate, 2 mM glutamine, 100 U/ml penicillin, 
100 g/ml streptomycin, and 10% FCS at 37ºC in a humidified atmosphere containing 5% 
CO2. The medium was replaced twice weekly until cells reached confluence. Confluent 
cells were washed 1x with sterile 1x PBS, and were detached by incubating at 37ºC, 5% 
CO2 with trypsin/EDTA solution. The cells were harvested with cell culture medium 
(DMEM, 10% FCS, 1x Penicillin/Streptomycin) and centrifuged at 1000 rpm for 3 min at 
room temperature (Centrifuge Eppendorf 5810R). The cell pellet was then resuspended in 
the appropriate medium and cells were plated in 10 cm diameter cell culture dishes at the 
appropriate density for maintenance or on glass coverslips for immunofluorescence.  
 
1.3. CELL COUNTING 
For the experiments the cells were seeded at a defined density (1x10
5 
cells/ml) on 
glass coverslips in 12 well dishes and allowed to grow for 24h. Cell counting was 
performed in a Fuchs-Rosenthal chamber (Depth 0.200 mm and 0.0625 mm
2
) and the 
following formula was used to calculate the amount of cells/ml: 
 
1 big square x 16 x 1000
3.2 μl
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1.4. CELL STORAGE AND FREEZING  
Cell stocks were made from dishes with confluent cells and low passages. After 
trypsinization and centrifugation the cell pellet was resuspended in freezing medium 
(DMEM with 20% FCS + 10% DMSO) and 1 ml aliquots were prepared in sterile cryotubes. 
Stocks (3x10
6
cells/ml) were frozen at -80ºC overnight and afterwards stored in liquid 
nitrogen.  
In contrast to the gradual process of freezing, all stocks were de-frozen quickly in a 
37ºC waterbath, resuspended in pre-warmed medium and placed in the incubator. The 
culture medium was replaced to allow attachment after 12h. 
 
2. DRUG TREATMENT 
2.1. INDUCTION OF PEROXISOME PROLIFERATION IN MAMMALIAN 
CELLS BY DIFFERENT STRESSORS 
To examine if different chemical stressors induce the growth/proliferation of the 
peroxisomal compartment, microtubule depolymerizing drugs (see Methods, Chapter 
2.1.1.), inhibitors of the mitochondrial respiratory chain (which lead to the production of 
intracellular ROS) (see Methods, Chapter 2.1.3. and Figure 9) as well as modifiers of 
intracellular GSH levels (see Methods, Chapter 2.1.2.) were applied. Twenty four hours 
after seeding, the cells were treated with different concentrations of the reagents. At 
different time intervals, cells were processed for immunofluorescence microscopy (see 
Methods, Chapter 3.) to monitor changes of the peroxisomal compartment. Furthermore, 
fluorescence-based assays were established which allowed the measurement of cellular 
ROS and GSH levels (see Methods 4.1. and 4.2.).  
 
2.1.1. MICROTUBULE-DEPOLYMERIZATION BY NOCODAZOLE  
 Nocodazole (NOC), a benzimidazole derivative, was initially developed as a 
potential anticancer drug. It is still widely used to study microtubule-dependent processes 
because of its ability to rapidly depolymerize microtubules (MTs) (inhibiting tubulin 
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polymerization) in vivo and in vitro (Vasquez et al., 1997).  It is also freely membrane-
permeable, and the microtubule-depolymerization is reversible. 
A nocodazole stock solution was made in DMSO at a final concentration of 33.2 
mM and stored in DMSO at -20ºC. The stock solution was diluted in culture medium at a 
final concentration of 33.2 μM. The exposure time was 3, 6 and 24h. After each time 
point cells cultured on glass coverslips were prepared for double-immunofluorescence 
and peroxisomes, mitochondria or microtubules were labelled with the appropriate 
antibodies (see Materials, Chapter 1., Table 3). 
 
2.1.2. DEPLETION OF GLUTATHIONE LEVELS BY L-BUTHIONINE 
SULFOXIMINE (BSO) 
 Glutathione (GSH), a ubiquitous tripeptide thiol (found in the cytoplasm, 
mitochondria and nucleus), is a critical component of the cellular antioxidant system. It is 
involved in many important cellular functions including the detoxification of xenobiotics, 
by the formation of less-toxic GSH-xenobiotic conjugates often requiring the catalytic 
activity of GSH S-transferases (GST) (Hayes et al., 2005) and the deactivation of ROS, 
either via direct GSH–ROS interaction or via the activity of GSH peroxidases (Dickinson 
and Forman, 2002). Thus, GSH is involved in both chemical detoxification and antioxidant 
defence (Green et al., 2006).  
 BSO induces oxidative stress in mammalian cells by irreversibly inhibiting γ-
glutamylcysteine synthetase (γ-GCS), an essential enzyme for the synthesis of GSH. 
Administration of BSO leads to decreased GSH levels in virtually all tissues including 
developing embryos, and a marked GSH depletion is associated with tissue damage. 
 A BSO stock solution was made (always fresh) in culture medium at a final 
concentration of 100 mM, filtered before use and then diluted in culture medium at a 
final concentration of 100 μM.  The time intervals of exposure were 3h, 6h, 9h, 12h and 
24h. After each time interval the cells were processed for immunofluorescence (see 
Methods, Chapter 3.).  
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2.1.3. INHIBITORS OF MITOCHONDRIAL RESPIRATION 
 
Figure 9. Electron transport chain (ETC) in the inner mitochondrial membrane. The ETC is composed of five multimeric 
complexes in the inner mitochondrial membrane. Complex I (NADH coenzyme Q reductase) accepts electrons from the 
Krebs cycle electron carrier nicotinamide adenine dinucleotide (NADH), and passes them to coenzyme Q (ubiquinine 
(UQ)), which also receives electrons from complex II (succinate dehydrogenase). UQ passes electrons to complex III 
(cytochrome bc1 complex), which passes them to cytochrome c (cyt c). Cyt c passes electrons to complex IV 
(cytochrome c oxidase), which uses the electrons and hydrogen ions to reduce molecular oxygen to water. The major 
ROS production occurs at complex I and III. (adapted from http://ccforum.com/content/pdf/cc6779.pdf). 
 
2.1.3.1. ROTENONE 
 Rotenone is a pesticide that was widely used as herbicide in private gardens and in 
several powders for delousing humans or animals (Srivastava and Panda, 2007). It is the 
most potent member of the rotenoids, a family of natural cytotoxic compounds extracted 
from various parts of Leguminosa plants and its toxicity is relevant. Due to its lipophilic 
structure it freely crosses cell membranes and accesses cytoplasm and mitochondria (Jin 
et al., 2007). Rotenone inhibits complex I (NADH CoQ1 reductase) (Figure 9) in the 
mitochondrial respiratory chain (Chance et al. 1963). Complex I inhibition has several 
potential functional consequences, including decreased ATP production, loss of proton 
gradient, bioenergetic defects and oxidative damage (Testa et al., 2005). 
 A rotenone stock solution was made in DMSO at a final concentration of 100 mM 
and stored in DMSO at -20ºC. The stock solution was diluted in culture medium at a final 
concentration of 100 nM, 500 nM, 1 μM, 10 μM and 100 μM and cells were incubated for 
6 and 24h of exposure time.  
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2.1.3.2. SODIUM AZIDE 
 Sodium azide blocks cytochrome c oxidase (complex IV) (Figure 9) by binding 
between the heme a3 iron and CuB in the oxygen reduction site (Yoshikawa et al., 1998; 
Fei et al., 2000). Many other heme proteins and other metalloenzymes are inhibited by 
azide binding to their metal centers. Azide also inhibits the ATP hydrolase activity of the 
mitochondrial F-ATPase. Cyanine and azide are extremely toxic because they bind tightly 
to the cell’s cytochrome oxidase complexes to stop electron transport, thereby greatly 
reducing ATP production and then leading to ROS production. 
 A sodium azide, stock solution (fresh solution) was made in culture medium at a 
final concentration of 10 mM, was filtered (with sterile syringe filter 0.2 µm cellulose 
acetate membrane, VWR international) before use and was then diluted at a final 
concentration of 10 μM, 1 mM and 10 mM. Cells were incubated for 3h, 6h, 24h and 48h. 
 
2.2. PRE-TREATMENT WITH ANTIOXIDANTS 
A pre-treatment with antioxidants was performed to investigate the involvement 
of ROS in peroxisome proliferation. This pre-treatment was performed 1h before the 
addition of the drugs (see Methods, Chapter 2.1.) with N-acetyl-cysteine (NAC), Vitamin C 
(ascorbic acid) and Vitamin E (α-tocopherol). The antioxidants remained in the culture 
medium until fixation (see Methods, Chapter 3.1.). 
 
2.2.1. N-acetyl cysteine  
 N-acetyl cysteine (NAC) is a well known antioxidant GSH precursor (Kelly, 1998), 
which can be rapidly converted into reduced glutathione (GSH). It provides cysteine for 
glutathione synthesis (Han and Park, 2009) after uptake by the cells, thus serving as an 
intracellular reducing agent (Meister, 1991). 
 A NAC stock solution, (100 mM; always fresh) was made in cell culture medium. 
The used concentration was 10 mM (after pH neutralization and sterilization of the stock 
solution by filtration). 
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2.2.2. Ascorbic acid  
 Ascorbic acid (vitamin C) is water-soluble and has been shown to be a major 
antioxidant in human plasma (May, 1999; Frei et al., 1990). It prevents mainly lipid 
hydroperoxide formation in plasma lipoproteins, e.g. LDL (low density lipoprotein) by 
reducing α-tocopherol (α-TOH) radicals formed upon reaction with lipid peroxyl radicals 
(Sies et al., 1992). Intracellularly, in the aqueous phase, vitamin C and GSH act to protect 
the cell from oxidative damage (Meister, 1995).  A vitamin C stock solution, (0.1%; always 
fresh) was made in cell culture medium. After pH neutralization and sterilization (by 
filtration) it was added to the cells at a final concentration of 0.01%. 
 
2.2.3. Vitamin E  
 Vitamin E is a lipid-soluble vitamin present in biological membranes. It contains a 
hydroxyl group by which it reacts with unpaired electrons reducing it, e.g. peroxyl radicals 
(Nordberg and Arner, 2001).  Vitamin E stock solution (50 mM; fresh or maximum storage 
for 1 day) was made in DMSO and added to the cells at a final concentration of 50 µM. 
 
3. MORPHOLOGICAL STUDIES 
3.1.  INDIRECT IMMUNOFLUORESCENCE 
 Cells grown on glass coverslips were washed twice with 1x PBS, fixed with pre-
warmed 4% paraformaldehyde (pH 7.4) for 20 min at RT (room temperature) and then 
washed three times with 1x PBS. Next, cellular membranes were permeabilized by 
incubation with 0.2% Triton-X 100 for 10 min at RT and the samples were blocked with 2% 
BSA. After blocking, the cells were washed 1-2 times in 1x PBS, and then incubated for 1h 
at RT with primary antibodies diluted in 1x PBS. After extensive washing in 1x PBS, cells 
were incubated with fluorescently labeled secondary antibodies diluted in 1x PBS (DαRb-
Alexa 488 or DαM-TRITC). For staining of the nucleus, cells were incubated with Höchst 
33258 for 2 min. To prepare the slides, the coverslips were washed one time in distilled 
water and mounted (after removal of excess water) in Mowiol 4-88 containing n-propyl 
galate as an anti-fading (Schrader et al., 1998b). 
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 For staining of microtubules, the cells were fixed and permeabilized with ice-cold 
methanol at -20ºC for 30 min. Then, samples were blocked with 2% BSA and treated as 
described above. The slides were stored at 4ºC in a proper box for immunofluorescence 
slides and kept in the dark. 
 
3.2.  FLUORESCENCE MICROSCOPY 
Samples were examined using an Olympus IX81 microscope (Olympus Optical, 
Hamburg, Germany) equipped with a PlanApo 100x/1.40 oil objective. Fluorescence 
images were acquired with an F-view II CCD camera (Soft Imaging System GmbH, 
Münster, Germany) driven by Soft imaging software. Digital images were optimized for 
contrast and brightness using appropriate software (Micrografx Picture Publisher (version 
8); Soft Imaging Viewer and PowerPoint). For quantitative analysis of peroxisomal 
morphology, 200–300 cells per coverslip were examined and categorized as cells with 
spherical (0.1–0.3 μm) or tubular (2–5 μm in length) peroxisomes as described previously 
(Schrader et al., 1996a). The counting was made blind and in different areas of the 
coverslip (see Methods, Chapter 6.). 
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4. BIOCHEMICAL ANALYSIS 
 
4.1.  MEASUREMENT AND QUANTIFICATION OF ROS PRODUCTION 
INDUCED BY DIFFERENT STRESSORS  
 
In order to detect and quantify ROS production and oxidative stress, a fluorescent 
based assay was established and developed in our group.   
 
Figure 10. Oxidation of H2DCFDA by ROS. H2DCFDA, 2′, 7′-dichlorodihydrofluorescein diacetate; H2DCF, 
dichlorofluorescein non fluorescent; DCF, dichlorofluorescein fluorescent (see Chapter I. 5.2.). 
  
 To establish this assay I cooperated with the group of Dr. Joaquín Jordan (Faculty 
of Medicine, University of Castilla-La Mancha, Albacete, Spain), and I spend some time in 
his laboratory. Furthermore, I was supported by Nina Bonekamp, a PhD student in our 
laboratory.  
 We used the sensitive fluorescent dye 2′, 7′-dichlorodihydrofluorescein diacetate 
(H2DCFDA) to measure the production of reactive oxygen species (ROS), mainly hydrogen 
peroxide and hydroxyl radicals (Figure 10). H2DCFDA freely enters the cell and is 
deacetylated by esterases to dichlorofluorescein (H2DCF). This non-fluorescent product is 
then converted by ROS into the fluorescent DCF, which can easily be detected by 
measuring the fluorescence at 530 nm when excited at 485 nm (Figure 10) (Fernandez-
Gomez et al., 2006; Perez-Ortiz et al., 2004).  
 During the establishment of the method in our laboratory, addition of H2O2 was 
used as a positive control for the presence of ROS. Thus, COS-7 cells were treated with 
increasing concentrations of H2O2 (100, 300, 500, 700 and 1000 µM). Furthermore, 
different concentrations of H2DCFDA (5, 10 and 100 µM) and different incubation times 
(10, 20, 30 min) were tested as well as different cell culture plates. We were testing 
multiwell plates with black or transparent wells. All wells tested had a flat bottom, 
H2DCFDA H2DCFDA
Cellular esterase activity
H2DCF
ROS
DCF
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transparent lid and were made of polystyrene. We finally selected 96-well culture plates 
with black wells which prevented fluorescence interference between neighboring wells. 
The following protocol for ROS measurement was determined: 
 Cells were seeded in 96-well culture plates (10
4 
cells/well) and the day after were 
treated with the different stressors already tested by immunofluorescence (see Methods, 
Chapter 2.). At different time points, the medium was removed and the cells were 
washed one time with 1x PBS. The PBS was removed, the cells were incubated with 
H2DCFDA (10 µM) and the fluorescence intensity was measured immediately during a 
period of 30 min (every 5 min) in a multifunctional microplate reader (TECAN i-control – 
infinite 200, Austria GmbH). An average of 4 to 6 wells per condition (untreated cells; cells 
incubated with the dye; a blank containing cell culture medium and dye; and H2O2 
together with the dye as a positive control) was measured. A mean value for each 
condition was determined. A linear increase of fluorescence with time was plotted and 
used to calculate a linear regression. This was used to determine the average relative 
percentage of ROS production from at least 3 independent experiments. Results were 
expressed as mean ± S.D. values, and statistical analysis was performed as described (see 
Methods, Chapter 6.). 
 
 
4.2.  MEASUREMENT OF GLUTATHIONE (GSH) LEVELS  
 
To verify the reduction of the levels of reduced GSH, another fluorescent based assay 
was established and developed in our group.     
 
Figure 11. Determination of GSH levels using mBCL. mBCL, monoclorobimane; GST, glutathione-S-transferase; GSH, 
reduced glutathione.  
GST
mBCL mBCL
mBCL - GSH
mBCL-GSH
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 This assay was developed in cooperation with the group of J. Jordan (Albacete, 
Spain). The intracellular levels of GSH were determined using monochlorobimane (mBCl) 
fluorescence. GSH is specifically conjugated to mBCl to form a fluorescent bimane-GSH 
adduct, in a reaction catalyzed by glutathione S-transferases (Figure 11). This conjugation 
reaction proceeds according to a first-order kinetic reaction and is followed by a second 
kinetic process that is many orders of magnitude slower and is thought to reflect the non-
enzymatic reaction of mBCl with other intracellular thiols (Jordan et al., 2004; Fernandez-
Gomez et al., 2006). 
 To establish this methodology in our group, a positive control for the depletion of 
GSH levels was made by treatment of the cells with increasing concentrations of BSO (50, 
100, 500 and 1000 µM), a known GSH depletory drug, and also for different time periods 
of incubation (10, 20 and 30 min). A linear decrease of the GSH levels was expected with 
increasing concentrations of BSO and also with time. The following protocol for GSH 
quantification was determined:  
 Cells were seeded in 96-well culture plates (10
4 
cells/well) and the day after were 
treated with the stressors described (see Methods, Chapter 2.). After different time 
points, the medium was removed and the cells were washed with 1x PBS and 100 µl of 
fresh Krebs buffer were added to each well. First a blank was measured (10 min) with 
Krebs buffer in a multifunctional microplate reader (TECAN i-control). After blank 
measurement the fresh Krebs buffer was removed and the cells were incubated with 100 
µl of 160 μM mBCl. The fluorescence was immediately measured every 3 min during a 
period of 30 min (37ºC) at an excitation wavelength of 340 nm and emission wavelength 
of 460 nm. An average of 4 to 6 wells per condition (untreated cells; cells incubated with 
mBCL; no cells - just the cell culture medium and mBCL; and different concentrations of 
BSO with the dye) were measured. A mean value for each condition was determined. A 
decrease of fluorescence with time was plotted and used to calculate a linear regression. 
This was used to determine the average relative percentage of GSH from at least 3 
independent experiments. Results were expressed as mean ± S.D. values, and statistical 
analysis was performed as described (see Methods, Chapter 6.). 
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5. CELL VIABILITY 
 In order to analyze the cell viability after drug treatment a cell viability assay was 
performed through a MTT assay using 3-[4, 5-dimethylthiazol-2-yl]-2, 5 
diphenyltetrazolium bromide (MTT). 
 This assay is a colorimetric approach that assesses cell viability by measuring 
mitochondrial function. MTT is a yellow colored tetrazolium salt that is reduced to a 
purple formazan (by the active cells). 
 Twenty four hours after drug treatment 100 µl of 0.5 mg/ml of MTT stock solution 
were added to cells seeded in 96 well culture plates. The samples were incubated at 37ºC 
and the purple formazan crystals were allowed to develop for 45 min (Perez-Ortiz, 2004). 
The MTT-containing medium was removed and 100 µl of DMSO were added to each well 
to dissolve the formed crystals. The absorbance was measured in a spectrophotometer 
(luminescence-spectrophotometer LS50B; Perkin-Elmer, Wellesley, MA, USA) at excitation 
wavelength of 545 nm and an emission wavelength of 680 nm. Cell viability analysis was 
complemented by morphological studies and cell counting (data is not shown). 
 
6. STATISTICAL ANALYSES 
For the morphological studies (see Methods, Chapter 3.), usually two coverslips 
per preparation were analyzed and three to five independent experiments were 
performed. For biochemical analysis (see Methods, Chapter 4.), four wells in a 96-well cell 
culture dish per each condition (untreated and treated cells) and per time of 
measurement (3h, 6h, 9h and 24h) were analyzed and at least three independent 
experiments were performed.  
Significant differences between experimental groups (both for morphological 
studies and biochemical analyses) were detected by analysis of variance for unpaired 
variables using Microsoft Excel software. Data are presented as means ± S.D., with an 
unpaired t test used to determine statistical differences. p values < 0.05 were considered 
as significant, and p values < 0.01 were considered as highly significant. 
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IV. RESULTS 
 It is now well established that peroxisomes have a key role in both the production 
and scavenging of reactive oxygen species (ROS). They are generators of oxygen stress but 
also a source of ROS signal mediators. Previous work from our group has demonstrated 
that oxidative stress (by external stimuli) induces morphological alterations of the 
peroxisomal compartment, which are linked to peroxisome proliferation (see Chapter I. 
6.). 
 To examine the effect of different ROS-producing stresses on peroxisomal 
dynamics, a suitable cell culture model had to be established. In the beginning three 
different cell lines (HepG2, COS-7-GFP-PTS1 and COS-7 cells) (see Methods, Chapter 1.1.) 
were analyzed by immunofluorescence microscopy to select a model with an elaborate 
and dynamic peroxisomal compartment suitable for induction of proliferation and the 
examination of peroxisomal dynamics. The cell culture model selected was the COS-7 cell 
line because these cells showed a good response to the stressors applied, as well as good 
viability and cell growth (based on morphological observations and cell viability 
measurements (see Methods, Chapter 5.)). Furthermore, morphological changes of the 
peroxisomal compartment could easily be visualized and quantitated due to the flatness 
of the cells and the very well defined peroxisome morphology. An example of spherical 
and tubular, elongated peroxisomes is presented in Figure 12.  
  
Figure 12. Peroxisome morphology in COS-7 cells shown by indirect immunofluorescence with an antibody to PMP70, a 
marker for the peroxisomal membrane, and DαRb-Alexa 488 as a secondary antibody. Peroxisomes are highly dynamic 
organelles with large plasticity, and spherical (A) as well as elongated-tubular (B) structures appear under normal cell 
culture conditions. N (Nucleus), Bars (20 μm). 
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 The stimuli tested were a cytoskeleton-active drug (nocodazole), inhibitors of 
mitochondrial respiration (rotenone and sodium azide) and a GSH-depletory drug (L-
Buthionine Sulfoximine). The morphological alterations of the peroxisomal compartment 
(as well as of mitochondria) were visualized and quantified by fluorescence microscopy.  
 Nocodazole is known to induce tubular peroxisomes (Schrader, 1996), therefore 
this drug was the first to be analyzed as a control for peroxisome elongation in COS-7 
cells. A general workflow for the experiment with the different stressors is shown in 
Figure 13. 
 
Figure 13. Experimental workflow. IMF, immunofluorescence 
CELL CULTURE MODEL SELECTION
MORPHOLOGICAL ALTERATIONS OF THE 
PEROXISOMAL COMPARTMENT?
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ARE ROS PRODUCED BY THE STIMULUS? 
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STATE?
PRE-TREATMENT WITH DIFFERENT ANTIOXIDANTS 
METHOD: IMF+ QUANTIFICATION
YES
EXAMINATION OF THE EFFECT OF DIFFERENT STIMULI ON THEIR ABILITY TO 
INDUCE PO PROLIFERATION (GROWTH/ELONGATION) AND DIVISION OF 
THE PO COMPARTMENT 
DETERMINATION OF OPTIMAL CONCENTRATIONS AND INCUBATION TIMES.
METHOD: IMF + QUANTIFICATION; CELL VIABILITY  ASSAY
IS ROS PRODUCTION BY THE STRESSOR INVOLVED IN PO ELONGATION?
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 This approach required the development of new assays that were not established 
in our laboratory, which are fluorescent-based assays to quantify ROS production and 
GSH levels. To establish these assays I cooperated with the group of Dr. Joaquín Jordán 
(Faculty of Medicine, University of Castilla-La Mancha, Albacete, Spain) and spend some 
time in his laboratory. Furthermore, I cooperated with Nina Bonekamp, a PhD student in 
our laboratory (see Methods, Chapters 4.1. and 4.2.).  
 
1. THE EFFECT OF NOCODAZOLE ON THE PEROXISOMAL 
COMPARTMENT 
 
1.1. NOCODAZOLE INDUCES PEROXISOME ELONGATION AND 
CLUSTERING 
 COS-7 cells (see Methods, Chapter 1.1.) were seeded on coverslips and after 24h 
were treated with 33.2 µM of nocodazole for 3, 6 and 24h (see Methods, Chapter 2.1.1.). 
At each time point cells were fixed with 4% PFA and prepared for immunofluorescence by 
permeabilization with 0.2% Triton-X 100 (see Methods, Chapter 3.1.). Peroxisomes were 
labeled with an antibody to PMP70 (a peroxisomal ABC transporter in the membrane). 
Microtubules were stained with an antibody to α-tubulin, and mitochondria with an 
antibody to TOM20 (a protein from the mitochondrial outer membrane involved in 
protein transport) (see Materials, Chapter 1. Table 3). 
 By fluorescence microscopy, 200-300 cells per coverslip were categorized as cells 
with spherical (0.1–0.3 μm) or tubular (2–5 μm in length) peroxisomes in controls 
(containing DMSO) and in nocodazole treated cells (see Methods, Chapter 3.2.). 
Simultaneously to peroxisome labeling, microtubules and mitochondria were stained. 
Images showing the morphological alterations of peroxisomes, mitochondria and 
microtubules are shown in Figure 14.  
 In cells cultured under normal, untreated conditions, peroxisomes are mainly of 
spherical shape (with about 10 – 20% of the cells exhibiting tubular peroxisomes) (Figure 
14 A and Figure 15). The mitochondrial compartment is composed out of filamentous and 
Results
Mestrado em Métodos Biomoleculares
60 
 
bulbous structures in COS-7 cells (Figure 14 F). Microtubules form a radial array 
originating from the MTOC (Microtubule Organization Center) (Figure 14 D). After 
nocodazole treatment microtubules were completely depolymerized as expected, and a 
cytoplasmic staining was observed (Figure 14 E). Mitochondria in nocodazole treated cells 
appeared fragmented (Figure 14 G), and peroxisomes were largely elongated (Figure 14 
B). In some cells also clustering of peroxisomes was observed (Figure 14 C).  
 
Figure 14. Microtubule-depolymerization induces peroxisome elongation. COS-7 cells were treated with the 
microtubule-depolymerizing drug nocodazole (+NOC) or solvent (Con) for 3, 6 and 24h (see Methods, Chapter 2.1.1) 
and processed for immunofluorescence microscopy using antibodies to PMP70 (A-C), a peroxisomal membrane protein, 
α-tubulin (D, E) or TOM20 (F, G), a mitochondrial outer membrane marker.  Note the elongated, tubular peroxisomes in 
(B), arrow, and the clustered peroxisomes in (C) in contrast to the spherical ones in (A). Boxed regions in C show a 
higher magnification view. Nocodazole treatment results in complete depolymerization of microtubules (E) and in 
fragmentation of mitochondria (G). N (Nucleus). Bar (20 μm). 
 
 As shown in Figure 15, the most pronounced effect on peroxisome dynamics 
occurred after 6h of nocodazole treatment showing 70 ± 7.44% of tubular peroxisomes in 
cells treated in contrast to 20 ± 4.23% in controls. After 3 and 24h there were no 
statistically significant differences between the cells treated and the controls. However, 
this is explained by the fact that the elongated peroxisomes start to divide giving rise to 
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spherical organelles (Schrader et al., 1996a) (see Chapter I. 3.). In summary, these 
observations show that peroxisomes respond to microtubule depolymerization with an 
elongation/tubulation (growth and division) of the peroxisomal compartment. In contrast, 
mitochondria are observed to fragment in the absence of microtubules. These 
observations confirm earlier studies on the effect of microtubule-active drugs on 
peroxisomes (Schrader et al., 1996a). However, the physiological significance of 
peroxisome elongation after microtubule depolymerization and the signaling pathways 
involved are largely unknown. 
 
Figure 15. Influence of the microtubule-depolymerizing drug nocodazole on peroxisome morphology in COS-7 cells. 
Cells were treated for 3, 6 and 24h with 33.2 µM of nocodazole (NOC). Data are from 3 to 6 independent experiments 
and are expressed as mean ± S.D. ** P < 0.01 when compared to control. 
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1.2. TREATMENT WITH NOCODAZOLE INDUCES AN INCREASE IN 
INTRACELLULAR ROS LEVELS 
 To investigate if the elongation of the peroxisomal compartment after 
depolymerization of microtubules is related to ROS production, intracellular ROS levels 
were measured after treatment of COS-7 cells with nocodazole. 
 A fluorescent based assay was established for the quantification of ROS 
production (see Methods, Chapter 4.1. for details). In the developed assay, the properties 
of the fluorescent dye 2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA) were 
exploited (Figure 10). The sensitive fluorescent dye H2DCFDA freely enters the cell and is 
deacetylated by esterases to dichlorofluorescein (H2DCF). This non-fluorescent product is 
then converted by reactive oxygen species into the fluorescent DCF, which can easily be 
monitored by measuring the fluorescence emitted at 530 nm when excited at 485 nm 
(see Methods, Chapter 4.1.).  
 ROS production was quantified in controls (containing DMSO) and in cells treated 
with nocodazole (Figure 16). ROS were measured for each condition and time point with 
an average number of 4-6 wells. For data presentation, means and standard deviation of 
the values from each experiment were calculated and presented as percentage of control. 
Six hours after nocodazole treatment, there was a significant increase in ROS production. 
 To verify if antioxidants can block ROS production, an antioxidant pre-treatment 
was performed. The cells were pre-incubated with the antioxidant NAC, VIT E and VIT C 
one hour before nocodazole addition (Figure 16). All antioxidants applied significantly 
reduced ROS production when compared to controls (Figure 16). 
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Figure 16. Intracellular ROS production induced by nocodazole in COS 7 cells.  ROS levels were quantified in control 
cells (CONT), in cells treated with nocodazole (NOC) (33.2 μM), in cells treated with the antioxidant alone, and in cells 
pretreated (1h before addition of NOC) with the antioxidants N-Acetyl cystein (NAC) (10 mM), Vitamin E (VIT E) (50 µM) 
and Vitamin C (VIT C) (0.01 %). Levels were quantified 6h after nocodazole addition. Data are expressed as percentage 
of control (mean ± S.D.) and are from 3 independent experiments. ** highly significant to control (P < 0.01); # significant 
to NOC, (P < 0.05).  
 
 From the data above we can conclude that nocodazole treatment induces the 
production of ROS, and all antioxidants tested were able to reduce the increase in ROS 
production induced by nocodazole. 
 
1.3. PEROXISOME ELONGATION INDUCED BY MICROTUBULE-
DEPOLYMERIZATION IS NOT DEPENDENT ON ROS PRODUCTION 
 To elucidate if ROS are responsible for peroxisome elongation, an antioxidant pre-
treatment was performed 1h before addition of nocodazole. The antioxidants used were 
NAC, VIT E and VIT C (see Methods, Chapter 2.2.). The analysis of the effect of the 
antioxidants was just performed 6h after nocodazole treatment since it was the time 
point with the maximum number of cells with tubular peroxisomes. Figure 17 shows the 
quantification of the effect of antioxidants on the tubulation of peroxisomes induced by 
nocodazole. Interestingly, none of the antioxidants tested was able to inhibit the 
elongation of the peroxisomal compartment in response to nocodazole (see above, Figure 
15). There were no differences in peroxisome morphology between the cells treated with 
nocodazole and antioxidants or nocodazole alone.  As shown by the statistical analysis 
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(Figure 17), antioxidants were not able to block the peroxisome elongation induced by 
nocodazole, indicating that the ROS increase was not the major cause for peroxisomal 
elongation induced by MT-depolymerization. 
 
 
Figure 17. Effect of antioxidants on the elongation of peroxisomes induced by nocodazole. Antioxidants (NAC, 10 mM; 
VIT E, 50 µM; VIT C, 0.01%) were added or not to COS-7 cells 1h before nocodazole (NOC) treatment. Antioxidants were 
kept in the cell culture medium during nocodazole treatment. Cells were also treated with antioxidants alone for the 
same period of time. 6 hours after addition of nocodazole, cells were fixed and prepared for immunofluorescence. Data 
are from 3 to 6 independent experiments and are expressed as mean ± S.D. ** highly significant to control (P < 0.01). 
There are no differences when compared to cells treated with nocodazole. 
 
 Nocodazole treatment affected the morphology of both peroxisomes and 
mitochondria (Figure 14). Although nocodazole induced ROS production, which was 
inhibited by antioxidants (Figure 16), the antioxidants were not able to block peroxisome 
elongation (Figure 17). Furthermore, the antioxidants neither inhibited mitochondrial 
fragmentation nor microtubule depolymerization induced by nocodazole (data not 
shown).  
 
1.4. NOCODAZOLE DOES NOT INDUCE ALTERATIONS OF THE GSH 
LEVEL 
Depolymerization of microtubules produced an increase in ROS levels inside the 
cell which might also lead to cellular alteration in the redox state. To analyze the redox 
state in the cell, GSH levels were measured with a fluorescent-based assay using 
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monochlorobimane (mBCl). Once added to the cell culture medium, mBCL is able to 
penetrate the plasma membrane and inside the cell, GSH can specifically conjugate to 
mBCl to form a fluorescent bimane-GSH adduct in a reaction catalyzed by glutathione S-
transferases (see Methods, Chapter 4.2., Figure 11). The GSH levels of control and 
nocodazole-treated cells were quantified after 3, 6, 9 and 24h. No statistically significant 
differences to control levels were found (Figure 18).  
 
Figure 18. Effect of nocodazole on GSH levels in COS-7 cells. Quantification of cellular GSH levels was performed after 
3, 6, 9 and 24h of NOC addition. Data are from 3 independent experiments and are expressed as mean ± S.D. There are 
no significant differences to the control. 
 
 Although nocodazole treatment induced ROS production, the GSH levels inside the 
cell were not grossly affected during the time intervals measured. This indicates that the 
redox state within the cells was not predominantly altered during treatment with 
nocodazole. 
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2. THE EFFECT OF BSO ON THE PEROXISOMAL COMPARTMENT 
 
2.1. BSO INDUCES PEROXISOME ELONGATION 
 Next, the cellular effect of L-Buthionine Sulfoximine (BSO), a compound which 
changes the redox state in the cell irreversibly inhibiting the rate-limiting enzyme of GSH 
synthesis (γ-glutamylcysteine synthase) (Griffith and Meister, 1979) was analyzed in 
regard to its capacity to induce ROS production and the possible resulting effect on 
peroxisome elongation/proliferation.  
 For treatment with BSO, cells were seeded on coverslips and after 24h 100 µM of 
BSO were added. Then, the cells were incubated for 3, 6, 9, 12 and 24h (see Methods, 
Chapter 2.1.2.). After each time point, cells were fixed with 4% PFA and prepared for 
immunofluorescence (see Methods, Chapter 3.1.). Peroxisomes were labeled with an 
antibody to PMP70 and mitochondria with an antibody to TOM20 (see Materials, Chapter 
1., Table 3). Afterwards, peroxisome morphology was evaluated by fluorescence 
microscopy, and for statistical evaluation, 200-300 cells per coverslip were categorized as 
cells with spherical (0.1-0.3 µm) or tubular peroxisomes (2-5 µm) in control and BSO-
treated cells.  
 In comparison to control cells (Figure 19 A), where peroxisomes were mainly of 
spherical shape, BSO-treated cells displayed a primarily elongated morphology of 
peroxisomes with the induction of long tubular peroxisomes (Figure 19 C). On the other 
hand, mitochondria in control as well as treated cells appeared as filamentous structures 
(Figure 19 B-D), thus there was no effect of BSO on mitochondrial morphology. 
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 The statistical evaluation of tubular peroxisomes after BSO treatment is shown in 
Figure 20. The major effect on peroxisome elongation occurred after 9h of BSO exposure. 
After 3h to 9h of treatment, there was already an increase in tubular peroxisomes 
indicating that peroxisomes respond to this GSH-depletory drug; after 9h to 24h the 
number of cells with tubular peroxisomes decreased; most likely elongated peroxisomes 
start to divide giving rise to new, spherical organelles.  
 
Figure 20. Influence of the GSH-depletory drug L-Buthionine Sulfoximine (BSO) on peroxisome morphology in COS-7 
cells. Cells were treated for 3, 6, 9, 12 and 24h with 100 µM of BSO. Data are representative for 3 to 6 independent 
experiments and are expressed as mean ± S.D. ** highly significant (P < 0.01) and * significant (P < 0.05) to control. 
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Figure 19. Depletion of cytosolic GSH 
levels induces peroxisome 
elongation. COS-7 cells were treated 
with 100 μM of BSO for 3, 6, 9, 12 and 
24h (see Methods, Chapter 2.1.2.) and 
examined by immunofluorescence 
microscopy using a PMP70 antibody 
to peroxisomes (A, C) and TOM20 to 
mitochondria (B, D). 9h after BSO 
treatment peroxisomes presented an 
elongated morphology (C) in contrast 
to the spherical ones in untreated 
cells (A). Boxed regions in C show 
higher magnification view. GSH 
depletion does not cause 
morphological changes of 
mitochondria after BSO treatment (D) 
when compared with untreated cells 
(B). N (Nucleus). Bar (20 μm).  
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2.2. BSO DEPLETES CELLULAR GSH LEVELS IN COS-7 CELLS 
 Glutathione (GSH) is a major component of the antioxidant defence system of 
mammalian cells being a critical component of the cellular antioxidant defense system 
and in the maintenance of the cellular redox potential (Jos et al., 2009). BSO is a well 
known GSH-depletory drug – acting by inhibition of γ-glutamyl cysteine synthase (γ-GCS) 
an essential enzyme of GSH synthesis, hence modulating the cellular redox state. 
 The cellular GSH levels were quantified by means of mBCL assay using a 96-well 
plate (see Methods, Chapter 4.2.) in untreated cells and cells treated with 100 µM of BSO, 
for 3, 6, 9 and 24h.  
 After BSO treatment, there was an early decline (3h) in cellular reduced 
glutathione levels that further decreased until 9h after BSO addition down to 33 ± 8.16%. 
Reduced GSH levels rose up again slightly after 24h of BSO addition (55 ± 6.93%) (Figure 
21).  
 
 
Figure 21. Effect of L-Buthione Sulfoximine (BSO) on GSH levels in COS-7 cells. Quantification of cellular GSH levels was 
performed after 3, 6, 9 and 24h of BSO addition. Data are from 3 independent experiments and are expressed as mean 
± S.D. ** highly significant (P < 0.01) when compared to control. 
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2.3. DEPLETION OF GSH LEVELS BY BSO INDUCES ROS PRODUCTION 
 To examine if the elongation of the peroxisomal compartment after depletion of 
GSH is related to ROS production, intracellular ROS levels were measured after 9 and 24h 
of BSO treatment through the DCF assay (see Methods, Chapter 4.1.). ROS were 
measured and quantified in 3 independent experiments, with measuring for each 
condition and time point an average number of 4-6 wells. For data presentation, means 
and standard deviation of the values from each experiment were calculated and related 
to the control and presented as percentage of control. 
 As shown in the Figure 22, BSO increases ROS production after 9 (195 ± 3.5%) and 
24 hours (218 ± 7%). 
 An antioxidant pre-treatment was performed 1h before BSO addition to verify if 
the antioxidants N-acetyl cysteine (NAC), Vitamin E (VIT E) and Vitamin C (VIT C) were 
able to reduce ROS production (Figure 22). All the antioxidants were able to decrease the 
ROS produced by BSO, both after 9 and 24h. 
 
Figure 22. Intracellular ROS production induced by L-Buthionine Sulfoximine (BSO) in COS 7 cells.  ROS levels were 
quantified in control cells (CONT), cells treated with BSO (100  μM), cells treated with the antioxidant alone, and also 
cells pretreated (1h before addition of BSO) with the antioxidants N-Acetyl cysteine (NAC) 10 mM), Vitamin E (VIT E) (50 
µM) and Vitamin C (VIT C) (0.01%). Data are derived from 3 independent experiments and are expressed as percentage 
of control (mean ± S.D). ** highly significant to control (P < 0.01); ## highly significant to BSO (P < 0.01). 
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 The decline in cellular glutathione (Figure 21) was followed by an increase in ROS 
production (Figure 22) which was reduced by NAC, VIT E and VIT C.  
 
2.4. ANTIOXIDANT PRETREATMENT INHIBITS PEROXISOME 
ELONGATION INDUCED BY BSO 
 To clarify if ROS are responsible for peroxisome elongation in response to BSO, 
cells seeded on coverslips were treated with the antioxidants NAC and VIT E 1h before 
addition of BSO. The percentage of cells with tubular peroxisomes was quantified after 9 
and 24h of BSO treatment (Figure 23). NAC is a well known antioxidant GSH precursor 
(Kelly, 1998), which can be rapidly converted into reduced glutathione (GSH) because it 
provides cysteine for glutathione synthesis. It thus serves as an intracellular reducing 
agent after uptake into the cell (Meister, 1991). However, metabolism of NAC to GSH 
requires glutamate-cysteine ligase [GCS; formally known as γ-glutamylcysteine synthetase 
(γ-GCS)], the enzyme that is inhibited by BSO. Thus, NAC is not able to block peroxisome 
elongation induced by BSO (Figure 23) (although it was able to reduce ROS production; 
maybe NAC is not so efficient in preventing morphological alterations of peroxisomes as 
the other antioxidants, at least in COS-7 cells). On the other hand, VIT E has a different 
mechanism of action, independent of the GSH mechanism, and was able to reduce 
peroxisome elongation. The effect of the antioxidants on peroxisome elongation is shown 
in Figure 23. 
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Figure 23. Effect of antioxidants on the elongation of peroxisomes induced by L-Buthionine Sulfoximine (BSO). 
Antioxidants (NAC, 10 mM; VIT E, 50 µM) were added or not to COS-7 cells 1h before BSO treatment. Antioxidants were 
kept in the cell culture medium during all the exposure time. Cells were also treated with antioxidants alone for the 
same period of time. 9 and 24h after BSO addition, cells were fixed and prepared for immunofluorescence microscopy. 
Data are from 3 to 6 independent experiments and are expressed as mean ± S.D. ** highly significant, P < 0.01; * 
significant, P < 0.05 when compared to controls. ## highly significant, P < 0.01 when compared to BSO. 
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3. EFFECTS OF INHIBITORS OF MITOCHONDRIAL RESPIRATION ON 
THE PEROXISOMAL COMPARTMENT 
 
3.1. ROTENONE INDUCES PEROXISOME ELONGATION 
 Next I examined whether inhibitors of the mitochondrial respiratory chain known 
to produce ROS exhibit an effect on peroxisome elongation/proliferation. The first 
compound tested was rotenone, a well known inhibitor of complex I. 
 Rotenone treatment was performed 24h after seeding of the cells on coverslips.  
Different concentrations of rotenone (100 nM, 1 µM, 10 µM and 100 µM) were tested as 
well as two incubation times, 6 and 24h (see Methods, Chapter 2.1.3.). After 6 and 24h 
cells were fixed with 4% PFA and prepared for immunofluorescence (see Methods, 
Chapter 3.1.) Peroxisomes were labeled with an antibody to PMP70 and mitochondria 
with an antibody to TOM20 (see Materials, Chapter 1., Table 3).  Afterwards cells were 
evaluated by fluorescence microscopy and for statistical evaluation 200-300 cells per 
coverslip were classified as cells with spherical (0.1-0.3 µm) or tubular (2-5 µm) 
peroxisomes in controls (containing DMSO) and in cells treated with rotenone. 
 Even at the lowest concentration (100 nM), rotenone induced morphological 
alterations in both peroxisomes and mitochondria (Figure 24). Whereas after rotenone 
treatment mitochondria appeared fragmented (Figure 24 E), peroxisomes appeared 
highly elongated (Figure 24 B). In samples treated with the highest concentration of 
rotenone (100 μM) a peroxisomal clustering was observed in some cells (Figure 24 C).  
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Figure 24. Rotenone induces peroxisome elongation and mitochondrial fragmentation. COS-7 cells were treated with 
rotenone (+ROT) for 6 and 24h (see Methods, Chapter 2.1.3.1.) and processed for immunofluorescence microscopy 
using antibodies directed to PMP70 (A-C) and to TOM20 (D-F). Note the elongated tubular peroxisomes in (B) and the 
clustering formation of peroxisomal clusters (arrows) in (C) in contrast to controls (A). Boxed regions in B show higher 
magnification view. Rotenone treatment results in a fragmentation of mitochondria (E, F). N (Nucleus), Bar (20 μm).  
 
 A statistical quantification of induction of tubular peroxisomes after rotenone 
treatment is displayed in Figure 25. The percentage of cells with tubular peroxisomes 
increased with rising rotenone concentrations, both after 6 and 24h. 
 
Figure 25. Effect of rotenone on peroxisome elongation. COS-7 cells were treated for 6 and 24h with different 
concentrations of rotenone. Data are from 3 to 6 independent experiments and are expressed as mean ± S.D. P < 0.01 
for all groups.  
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3.2. ROS ARE PRODUCED IN COS-7 CELLS AFTER ROTENONE 
TREATMENT 
 Rotenone interferes with the mitochondrial electron transport chain, by inhibiting 
the transfer of electrons from iron-sulfur centers in complex I to ubiquinone (Figure 9). 
This prevents NADH from being converted into usable cellular energy (ATP) and 
consequently leads to ROS production. To examine if peroxisome elongation is the 
consequence of rotenone-dependent ROS production, intracellular ROS levels were 
quantified in cells under control conditions and after treatment with the lowest rotenone 
concentration (100 nM). ROS were measured by the DCF assay (see Methods, Chapter 
4.1.) in 3 independent experiments with measuring for each condition and time point an 
average number of 4-6 wells. For data presentation, means and standard deviation of the 
values from each experiment were calculated and related with controls. Data are 
presented as percentage of control. 
 As displayed in Figure 26, rotenone increases ROS production in COS-7 cells after 
6h (276 ± 6%) and 24h (414 ± 18%) when compared to control conditions. 
 An antioxidant pre-treatment was carried out 1h before rotenone addition in 
order to verify that the antioxidants were able to reduce ROS produced by rotenone. All 
antioxidants were able to reduce ROS produced by rotenone after 6 and 24h (Figure 26). 
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Figure 26. Intracellular ROS production induced by rotenone in COS 7 cells.  ROS levels were quantified in control cells 
(CONT), cells treated with rotenone (ROT) (100 nM), cells treated with the antioxidant alone, and also cells pretreated 
(1h before addition of ROT) with the antioxidants N-Acetyl cysteine (NAC) (10 mM), Vitamin E (VIT E) (50 µM) and 
Vitamin C (VIT C) (0.01%). Data are expressed as percentage of control (mean ± S.D.) and are from 3 independent 
experiments ** highly significant to control (P < 0.01); * significant to control (P < 0.05); ## highly significant to ROT (P < 
0.01). 
 
 
3.3. ROS GENERATED BY MITOCHONDRIA ARE NOT INVOLVED IN 
PEROXISOME ELONGATION INDUCED BY ROTENONE 
 To elucidate if ROS produced by mitochondria are responsible for elongation of 
the peroxisomal compartment in response to rotenone, cells were treated 1h before 
rotenone addition with the antioxidants NAC and VIT E (see Methods, Chapter 2.2.). 
Different concentrations of rotenone (100 nM, 1 µM and 100 µM) were analyzed together 
with the antioxidant treatment after 6 and 24h (Figure 27). Interestingly, none of the 
antioxidants tested was able to block the peroxisome elongation induced by rotenone 
neither after 6 nor 24h, indicating that the increase in ROS levels was not the main cause 
for peroxisomal elongation induced by rotenone. 
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Figure 27. Effect of antioxidants on the elongation of peroxisomes induced by rotenone. Antioxidants (NAC, 10 mM 
and VIT E, 50 µM) were added or not to COS-7 cells 1h before rotenone (ROT) addition. We tested different 
concentrations of ROT (100 nM, 1 µM and 10 µM) together with antioxidants and also control cells (CONT). Antioxidants 
were kept in the cell culture medium during all the exposure times. Cells were also treated with antioxidants alone for 
the same period of time. 6 and 24h after ROT addition, cells were fixed and prepared for immunofluorescence. Data are 
from 3 to 6 independent experiments and are expressed as mean ± S.D. All groups are highly statistically significant to 
controls (P < 0.01) except for NAC (6h) and VIT E (24h). 
 
 Interestingly, the morphological alterations observed for mitochondria after 
rotenone treatment (Figure 24) were also not inhibited by antioxidants (data not shown). 
 
3.4. ROTENONE DEPLETES INTRACELLULAR GSH LEVELS 
 Rats treated with rotenone in vivo have been used as a model to reproduce the 
neurochemical, neuropathological and behavioral features of Parkinson’s disease (PD) 
and a decrease in  glutathione levels has been implicated early on in PD (Chinta and 
Andersen, 2006). 
 Thus, we analyzed the redox state in COS-7 cells treated with rotenone through 
the mBCL assay (see Methods, Chapter 4.2.). In 3 independent experiments, an average 
number of 4-6 wells was used for measuring the GSH levels in each condition and time 
point. For data presentation, averages and standard deviations of the values from each 
experiment were calculated and related to the control as percentage of control. 
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 After 6 and 24h GSH levels of control and rotenone-treated cells were quantified.  
After rotenone treatment (100 nM), GSH levels decreased to 86 ± 3.46% after 6h and to 
59 ± 2.89% after 24h (Figure 28).  
 
Figure 28. Effect of rotenone on GSH levels in COS-7 cells. Quantification of cellular GSH levels was performed after 6 
and 24h of ROT (100 nM) treatment. Data are from 3 independent experiments and are expressed as mean ± S.D. ** 
highly significant (P < 0.01) when compared to control. 
 
 Thus, rotenone induced both ROS production and depletion of GSH levels. 
However, ROS produced by rotenone were not the main cause for peroxisome elongation 
(Figures 25 and 27). 
 
3.5. PEROXISOME ELONGATION INDUCED BY ROTENONE IS 
DEPENDENT ON MICROTUBULE DEPOLYMERIZATION 
 Based on the observed clustering of peroxisomes in cells treated with the highest 
concentration of rotenone, we decided to stain the microtubules with an antibody to α-
tubulin in cells treated with rotenone. Surprisingly, at the highest concentration, 
rotenone induced the complete depolymerization of microtubules (Figure 29).  However, 
at the lowest concentration (100 nM) microtubules were still visible and appeared 
unaffected. As shown in Figure 29, at low rotenone concentrations (100 nM and 1 µM), 
microtubules form a radial array originating from the MTOC similar to control conditions, 
but at higher concentrations (10 µM and 100 µM) microtubules are completely 
depolymerized and peroxisomes are clustered.  
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Figure 29. Rotenone induces microtubule depolymerization. COS-7 cells were treated with low (100 nM) and high 
concentrations (100 μM) of rotenone (ROT) for 6 and 24h (see Methods, Chapter 2.1.3.1.) and peroxisomes and 
microtubules were visualized by immunofluorescence microscopy using PMP70 antibodies to peroxisomes (A-C) and α-
tubulin antibodies to microtubules (D-F). With the lowest concentration of ROT (100 nM) peroxisomes (B) are elongated 
(see Figure 24) and microtubules appear to be intact (E) compared with controls (D). However, with the highest 
concentration of rotenone (100 μM) microtubules are completely depolymerized (F) and the peroxisomes are elongated 
and clustered (C), arrows. N (Nucleus), Bar (20 μm).   
 
 To check for microtubule integrity at low rotenone concentrations, microtubules 
were stained with an antibody to acetylated α-tubulin. Acetylated α-tubulin is present in 
various microtubule structures and plays a role in the stabilization of microtubules.  
 Cells were treated with low concentrations of rotenone for 6, 24 and 48h. For 
visualization of microtubules, cells were fixed and permeabilized with methanol (see 
Methods, Chapter 3.1.). Microtubules were labeled with an antibody to α-acetylated 
tubulin (see Materials, Chapter 1., Table 3) (Figure 30). In control cells only a few 
microtubules were labeled per cell (Figure 30 A). Cells treated with 100 nM of rotenone 
were markedly different: the number of cells showing acetylation of tubulin was much 
higher than in controls. Furthermore, almost all microtubules in a given cell showed 
labeling for acetylation (Figure 30 B). 
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Figure 30. Rotenone induces microtubule acetylation. Microtubules after rotenone treatment were labeled with α-
acetylated tubulin antibody. COS-7 cells were treated with 100 nM of rotenone (ROT) and fixed with methanol after 6, 
24 and 48h. There is an increase in cells with acetylated microtubules after rotenone treatment indicating stabilization 
of microtubules. N (Nucleus), Bar (20 μm). 
 
 Figure 31 shows the quantification of the cells labeled for acetylated tubulin under 
normal culture conditions and in rotenone treated cells. In controls, cells showing 
acetylated tubulin were present in low frequency (49 ± 7.07% after 6h; 46 ± 3.36% after 
24h and 23 ± 4.24% after 48h). A significant increase was visible in cells treated with 100 
nM and 500 nM of rotenone after 6h to 48h. The concentration of 10 µM was not tested, 
since at this concentration microtubules were completely depolymerized. 
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Figure 31. Labeling of microtubules with α-acetylated tubulin in cells treated with low concentrations of rotenone. 
Cells were treated with 100 nM, 500 nM of Rotenone (ROT) for 6, 24 and 48h. After each time point, cells were fixed 
and permeabilized with methanol and prepared for immunofluorescence (see Methods, Chapter 3.1.). Cells were 
counted as labeled or not labeled by the α-acetylated tubulin antibody. Data are derived from 3 independent 
experiments and are expressed as mean ± S.D. (P < 0.01 for all groups). 
 
 In summary, rotenone induced peroxisome elongation and also clustering at 
higher concentrations. Although ROS were generated in mitochondria after rotenone 
treatment, they are presumably not the main cause of peroxisome elongation induced by 
rotenone because the antioxidants were not able to block the peroxisome elongation. 
Rotenone is also responsible for alterations in the cellular redox state as well for 
modifications in the structure of the microtubule cytoskeleton. Thus, it is likely that 
microtubule depolymerization induced by rotenone is the main cause for peroxisome 
elongation. 
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3.6. THE COMPLEX IV INHIBITOR, SODIUM AZIDE, HAS A SLIGHT 
EFFECT ON THE PEROXISOMAL COMPARTMENT 
 Sodium azide (NaN3) is known as an inhibitor of cytochrome c oxidase residing in 
the mitochondrial inner membrane and interferes with cellular respiration, particularly in 
the complex IV (Figure 9). NaN3 was the next stimulus to be analyzed in its capacity to 
induce ROS production and its potential effect on peroxisome proliferation.  
  Sodium azide treatment was performed 24h after seeding the cells on coverslips.  
Different concentrations of sodium azide (10 µM, 1 mM and 10 mM) as well as three time 
periods of incubation (6, 24 and 48h) were tested (see Methods, Chapter 2.1.3.2.). After 
each time point, cells were prepared for immunofluorescence and then visualized and 
evaluated by fluorescence microscopy. For statistical evaluation, 200 – 300 cells per 
coverslip were categorized as cells with spherical or tubular peroxisomes in control and 
sodium azide-treated cells.  
 In COS-7 cells cultured under normal, untreated conditions peroxisomes were 
mainly of spherical shape (Figure 32 A) and mitochondria showed a normal tubular 
morphology (Figure 32 D). After drug treatment, morphological alterations of the 
peroxisomal compartment were not so pronounced comparing with the other stimuli 
already tested here (Figure 32 B). However, the mitochondrial compartment was 
dramatically affected (Figure 32 E). Mitochondria after sodium azide treatment displayed 
a fragmented morphology and showed swelling (more frequent at the higher 
concentration, 10 mM) (Figure 32 F).   
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Figure 32. Sodium Azide (NaN3) failed to induce changes in peroxisome morphology. COS-7 cells were treated with 10 
μM, 1 mM and 10 mM for 6, 24 and 48h (see Methods, Chapter 2.1.3.2.) and prepared for imunofluorescence 
microscopy using PMP70 antibody to peroxisomes (A-C) and TOM20 antibody to mitochondria (D-F). Mitochondria 
showed a fragmented morphology (E, F) with swelling, whereas peroxisomes were not elongated (B, C). N (Nucleus), 
Bar (20 μm).  
 
 The quantification of induction of tubular peroxisomes after sodium azide 
treatment is shown in Figure 33. The first concentrations tested were 10 µM and 10 mM 
for 24 and 48h. As there was no effect on peroxisomes, another concentration (1 mM) 
and an earlier time point (6h) was tested. Only when high concentrations were applied 
(10 mM for 24h), a slight effect on peroxisome elongation was observed (30 ± 4.71%) 
when compared to controls (16 ± 5.61%). After 48h with 10 mM sodium azide a 
pronounced reduction occurred in the number of cells indicative for a toxic effect.  
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Figure 33. Effect of sodium azide, a complex IV inhibitor of mitochondrial respiration, on peroxisome morphology in 
COS-7 cells. Cells were treated for 6, 24 and 48h with different concentrations of NaN3. Data are derived from 3 
independent experiments and are expressed as mean ± S.D. * significant (P < 0.05) when compared to control.  
 
 As the effect on the morphology of the peroxisomal compartment was not so 
pronounced, despite a strong effect on mitochondrial morphology, a quantification of 
ROS production as well as a pre-treatment with antioxidants was not performed.  
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V. DISCUSSION AND CONCLUSIONS 
 Mammalian cells contain hundreds of peroxisomes under normal growth 
conditions, suggesting that there are constitutive mechanisms for raising peroxisome 
abundance above one per cell. Peroxisome increase in response to extracellular stimuli is 
indicative for the existence of signal transduction pathways that exert additional control 
over peroxisome abundance. 
 In cultured cells, oxidative stress has been shown to induce morphological changes 
of the peroxisomal compartment, which are linked to peroxisome proliferation (Schrader 
and Fahimi, 2006b). In mammalian cells a pronounced elongation of peroxisomes is 
observed after UV irradiation, direct exposure to H2O2, or during live cell imaging of GFP-
PTS1 labeled peroxisomes by regular fluorescent microscopy (Schrader et al., 1999; 
Schrader and Fahimi, 2004).  
 Evidence has been presented in the last years that peroxisome elongation appears 
to be an important prerequisite of peroxisome division, and that tubulation and fission of 
elongated peroxisomes represent processes of peroxisomal growth and division, which 
contribute to peroxisome proliferation (Schrader and Fahimi, 2006b). Because 
peroxisomes harbor most of the enzymes for catabolism of ROS, the tubulation and 
expansion  of the peroxisomal compartment appears to be a logical response to the 
oxidative stress and could have a cell rescue function against the destructive effects of 
ROS (Schrader et al., 1999).  
 The general aim of this study was to investigate if different types of stresses 
applied to the cells will lead to intracellular ROS production and will be capable of 
inducing growth/proliferation of the peroxisomal compartment. Such an approach 
required the selection of a mammalian cell culture system suitable for the induction of 
peroxisome proliferation in addition to the examination of the effect of different stressors 
on the induction of peroxisomal growth/proliferation. Testing different types of stresses 
could help us to elucidate not only if ROS are involved in peroxisome elongation but also 
where the ROS responsible for this response come from.  
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1. Microtubule-depolymerization and peroxisomes: still a mysterious 
relationship 
 It has already been described that microtubule depolymerizing drugs (e.g. 
nocodazole) induce elongation of the peroxisomal compartment (Schrader et al., 1996a). 
However, it was not clear if this morphological alteration was ROS-dependent or if ROS-
independent signalling events lead to peroxisomal elongation. 
 Here we observed that in COS-7 cells nocodazole induced peroxisome elongation 
and also clustering (Figure 14) as already described in HepG2 cells (Schrader et al., 
1996a). In addition, it was observed that mitochondria fragmented upon nocodazole 
treatment. The microtubules were also depolymerized (Figure 14) as expected, since 
nocodazole is a well known microtubule-depolymerizing drug. 
 We demonstrated that microtubule depolymerization induced by nocodazole 
increased intracellular ROS production (Figure 16). Although antioxidants were capable to 
diminish the ROS produced, they were not able to inhibit peroxisome elongation (Figure 
17) indicating that increased ROS levels were not involved in peroxisome elongation. 
Moreover, mitochondria were not able to recover their normal morphology by the 
antioxidant pre-treatment (data not shown). 
 Interestingly, after microtubule depolymerization most of the subcellular 
organelles fragment, for example mitochondria or the ER. In contrast, peroxisomes form 
elongated tubular structures, thus rising the question why peroxisomes behave 
differently, as they are also known to interact with microtubules (Thiemann et al., 2000; 
Schrader et al., 2003). 
 It has already been reported that the binding capacity of peroxisomes to 
microtubules can be affected by the addition or depletion of ATP (Schrader et al., 2003). 
While the addition of ATP or motor proteins such as kinesin and dynein were shown to 
increase the binding capacity of isolated peroxisomes to microtubules in vivo, ATP-
depletion or the addition of microtubule-associated proteins (MAPs) decreased it. In 
addition, mitochondrial fragmentation induced by microtubule depolymerization can 
produce ROS and also decrease ATP production. This might affect the binding between 
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peroxisomes and microtubules and consequently lead to peroxisome elongation. 
Alternatively, peroxisome elongation is triggered by depolymerization of microtubules 
itself, most likely due to the mechanical link between peroxisomes and microtubules, as 
the microtubules are essential for proper peroxisome distribution and movement in the 
cell (Schrader et al., 2003). 
 Another possibility is that microtubule-depolymerization induced by nocodazole 
mimics entry in mitosis. Elongation of peroxisomes might be the first step of peroxisome 
proliferation to deliver a sufficient number of peroxisomes to the daughter cell before 
cytokinesis. However, the reason why peroxisomes elongate after microtubule 
depolymerization is still unclear and the relationship between peroxisomes and 
microtubules remains mysterious. 
 
2. Peroxisome dynamics are sensitive to changes in intracellular redox 
state  
 Depletion of GSH has been shown to trigger oxidative stress (Reliene and Schiestl, 
2006). L-Buthionine sulfoximine (BSO) is a well known specific agent for inhibiting GSH 
biosynthesis and thereby causing GSH depletion (Griffith, 1982). BSO has been used in a 
number of biochemical and pharmacological studies, enhancing the apoptotic effect of 
several chemotherapeutic agents (Lewis-Wambi et al., 2009). 
 In the present work we measured a significant depletion of cellular GSH after BSO 
treatment in COS-7 cells. Interestingly, the depletion of cellular GSH levels had a 
significant effect on the peroxisomal compartment inducing the formation of long tubular 
peroxisomes (Figure 19). The most pronounced effect occurred after 9h of BSO treatment 
(Figure 20) when GSH levels reached their minimum (Figure 21). In BSO treated cells, 
mitochondrial morphology was similar to untreated cells (Figure 19). Bowes and Gupta 
(2005) have shown that pharmacological depletion of GSH pools results in the formation 
of an elongated mitochondrial reticulum suggesting a link between GSH, redox status and 
organelle morphology. 
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 We showed that BSO treatment increased the intracellular ROS levels more 
prominently after 9 and 24h (Figure 22) in parallel with the maximal peroxisome 
elongation (Figure 20) as well as with the minimal GSH levels (Figure 21).  
 To elucidate the involvement of ROS in peroxisome elongation induced by BSO, an 
antioxidant pre-treatment was performed with the antioxidants NAC and VIT E. 
Interestingly, VIT E, in addition to its ability to diminish ROS production and GSH 
depletion, also inhibited peroxisome elongation – indicating that ROS are involved in 
peroxisome elongation induced by BSO. A similar effect was shown by Schrader et al. 
(1999): in HepG2 cells elongation of peroxisomes was induced by UV irradiation but was 
blocked by antioxidant pre-treatment thus supporting the role of ROS in UV-mediated 
peroxisomal growth. 
 However, NAC was not able to block peroxisome elongation. One possible 
explanation is that the metabolism of NAC to produce GSH requires γ-GCS, which is the 
enzyme that is inhibited by BSO. In agreement with this, Reliene and Schiestl (2006) 
showed that NAC did not replenish GSH in NAC plus BSO treated mice. Although in 
another study, NAC rescued cells from toxic effects induced by dopamine and enhanced 
by BSO (Offen et al., 1996). Furthermore in the present study, NAC was able to reduce 
ROS production and to prevent the GSH depletion induced by BSO. This can be explained 
by the existence of a wide variety of antioxidant systems that scavenge ROS in a cell, or 
maybe a small amount of ROS that was not scavenged by NAC was sufficient to act on 
peroxisome morphology. 
 Vitamin E is the most important lipid soluble antioxidant and protects cell 
membranes from oxidation by reacting with lipid radicals. The inhibition of peroxisome 
elongation by vitamin E might indicate that BSO is acting on peroxisomal membranes. 
 From these data, we can conclude that peroxisomes (like mitochondria) are 
sensitive to changes in the intracellular redox state, and that ROS that are generated in 
the cytosol may induce peroxisome proliferation. 
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3. The peroxisome – mitochondria connection: looking at mitochondrial 
ROS production  
 There is growing evidence now that both, peroxisomes and mitochondria exhibit a 
closer interrelationship than previously thought. This connection includes metabolic 
cooperations and cross-talk (Schrader and Yoon, 2007), a novel putative mitochondria-to-
peroxisome vesicular trafficking pathway (Neuspiel et al., 2008), as well as an overlap in 
key components of their fission machinery (Schrader and Fahimi, 2006a). Thus, 
peroxisomal alterations in metabolism, biogenesis, dynamics and proliferation can 
potentially influence mitochondrial functions, and vice versa (Camoes et al., 2009). The 
examination of inhibitors of the mitochondrial respiratory chain is therefore important to 
elucidate if ROS generated in mitochondria can induce morphological changes of the 
peroxisomal compartment. 
 The first mitochondrial inhibitor tested was rotenone. This drug is a well known 
complex I inhibitor of the mitochondrial respiratory chain and has been widely used to 
study Parkinson’s disease (PD). In the present work, rotenone was used to induce ROS 
production via the mitochondrial compartment, and to examine the effect on peroxisome 
dynamics. 
 We showed that low concentrations of rotenone (100 nM) induced elongation of 
the peroxisomal compartment (Figure 24). Moreover, the mitochondrial morphology was 
also affected leading to a more fragmented phenotype (Figure 24).  
 We demonstrated in this work, that 100 nM of rotenone significantly increased 
ROS production in COS-7 cells (Figure 26) and, although all the antioxidants tested were 
capable to decrease the ROS levels produced (Figure 26), they were surprisingly not able 
to inhibit peroxisome elongation (Figure 27). These data reveal that ROS generated in 
mitochondria by rotenone are presumably not responsible for the elongation of 
peroxisomes.  
 We also showed that 100 nM of rotenone were able to deplete cellular GSH levels 
after up to 6 to 24 hours of treatment. Decreased levels of reduced glutathione, induced 
by rotenone, have been implicated in PD (Sian et al., 1994, Chinta and Andersen, 2006). 
Actually, glutathione depletion is the earliest reported biochemical change in the 
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dopaminergic neurons of the substantia nigra (SN) in PD (Perry et al., 1982). Decreases in 
glutathione availability in the brain promote morphological alterations of mitochondria, 
most likely via increased levels of oxidative or nitrosative stress in this organelle (Jain et 
al., 1991).  
 Thus, the elongation of the peroxisomal compartment might be related to the 
depletion of the cellular GSH pool and would indicate that peroxisomal dynamics are 
sensitive to changes in intracellular redox state. 
 However, this is still not completely clear because rotenone also exhibited an 
effect on microtubules. The cluster formation of peroxisomes induced by high rotenone 
concentrations (10 and 100 µM) was very surprising. When microtubules were labeled 
with an antibody to α-tubulin at low rotenone concentrations (100 nM and 1 µM) they 
showed a normal radial array originating from the MTOC (Figure 29 E). However, at higher 
concentrations (10 and 100 µM) they were completely depolymerized (Figure 29 F). Thus, 
at higher rotenone concentrations peroxisome elongation is presumably related to 
microtubule-depolymerization.   
 Acetylated α-tubulin is present in various microtubule structures and plays a role 
in stabilizing them. Using an antibody to acetylated tubulin we observed that at low 
rotenone concentrations (100 nM and 500 nM) microtubules were already modified. A 
pronounced staining for acetylated tubulin was found in cells treated with the lowest 
rotenone concentrations (100 nM and 500 nM) (Figure 30, 31) contrary to controls. Thus, 
rotenone is already affecting microtubule stability at low concentrations.  
 As rotenone interferes with mitochondrial respiration, redox state and 
microtubules, it is difficult to interpret its effect on peroxisome elongation. It is, however, 
likely that its microtubule-depolymerizing activity is responsible for alterations of the 
peroxisomal compartment. 
 The second mitochondrial inhibitor tested in this work was sodium azide, an 
inhibitor of cytochrome c oxidase (complex IV), which is located in the mitochondrial 
inner membrane. Sodium azide has been described to inhibit cellular respiration and 
consequently decreases ATP levels (Sato et al., 2008).   
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 After treatment with sodium azide no significant morphological changes of the 
peroxisomal compartment (e.g. elongated peroxisomes) (Figure 32 B, 33) were observed. 
However, mitochondria were dramatically affected showing a completely fragmented 
morphology (Figure 32 E, F). Moreover, at the highest concentration (10 mM, 24h 
treatment) mitochondria appeared swollen. 
 Sodium azide is also known as a potent inhibitor of superoxide dismutase and 
catalase activities (Chang and Lamm, 2003; Richardson et al., 1983). Few studies have 
been devoted to analyzing the effects of chronically lowering the functional level of 
catalase within cells as well as how peroxisome morphology is affected after catalase 
inhibition. Catalase inhibition (by 3-amino-1,2,4-triazole (3-AT)) results in hydrogen 
peroxide accumulation (Koepke, 2008) and also reduces cell growth and induces 
peroxisome proliferation (Koepke, 2008; Terlecky, 2006). Peroxisome elongation occurs 
before peroxisome fission – steps that lead to peroxisome proliferation. This way catalase 
inhibition might be the reason for the slight effect in the elongation of peroxisomes 
observed. 
 Other data from our laboratory indicate that the drugs malonate and 3-NP (3-
nitroprionate) which act on mitochondrial respiration do not have an effect on 
peroxisome morphology as well (unpublished data). Malonate and 3-NP are inhibitors of 
succinate dehydrogenase (complex II). This inhibition is capable of producing high 
amounts of superoxide and subsequent oxidative damage when applied to cells in culture 
or injected in animals (Gomez-Nino et al., 2009; Fernandez-Gomez et al., 2005).  
 6-Hydroxydopamine (6-OHDA), an oxidative metabolite of dopamine, is a 
neurotoxin which has been broadly used to generate experimental models of Parkinson’s 
disease (PD) (Bove et al., 2005; Blum et al., 2001). Although there is a consensus in the 
ability of 6-OHDA to induce cytotoxicity in different cell types (Fernandez-Gomez et al., 
2006; Galindo et al., 2003), the mechanism involved is still controversial (Blum et al., 
2001). Among the mechanisms discussed, the generation of reactive oxygen species (ROS) 
is the most accepted (Galindo et al., 2003). 6-OHDA induced profound mitochondrial 
fragmentation in SH-SY5Y cells (human neuroblastoma from neuronal tissues), but failed 
to induce any changes in peroxisome morphology (Gomez-Lazaro et al., 2008). 
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 Taking together all the results, it is not likely that ROS generated in mitochondria 
or manipulations of the respiratory chain complexes I, II, IV are a sufficient stimulus for 
peroxisome elongation/proliferation. However, changes in cellular redox state have the 
capacity to stimulate peroxisome elongation. It will be a challenge for future studies to 
unveil the signalling pathway(s) involved. 
 
4. The rotenone problem  
 Rotenone has been used to induce PD-like symptoms (in vivo) or to study the 
mechanisms of toxicity in cells (in vitro). However, in some studies the strategy is not 
properly addressed. Some authors do not take into consideration that rotenone has two 
sites of action (complex I inhibition and microtubule depolymerization). In many in vivo 
studies the main reason for PD development is supposed to be the oxidative stress 
generated by inhibiting complex I (Verma and Nehru, 2009; Testa et al., 2005; Sherer et 
al., 2003; Chinta and Andersen, 2006). These data have to be interpreted with care. 
However, there are also studies where the authors address that microtubule 
depolymerization by rotenone might be one of the main causes of PD symptoms, e.g. by 
inhibiting organelle transport (Brinkley et al., 1974; Marshall and Himes, 1978; Srivastava 
and Panda, 2007).  
 Our data indicate that in vivo studies with rotenone have to be carefully 
interpreted. ROS production via complex I is not the only effect when dealing with cells or 
whole organisms. However, experiments with isolated mitochondria (in vitro) should not 
encounter side effects. 
 In this work we showed that together with the increased ROS production, 
depletion of GSH levels and microtubule depolymerization – aspects that have been 
reported in PD – rotenone also has an effect on peroxisome elongation/proliferation. This 
might indicate that the peroxisomal compartment is also important for Parkinson’s 
disease. Peroxisomal elongation/proliferation might exert a protective function in PD, and 
is therefore important for the role of peroxisomes in health and disease. 
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5. FINAL CONCLUSIONS 
Taking together all results we can conclude from this work that: 
1. Peroxisome elongation induced by microtubule-depolymerization is not 
dependent on ROS production. 
2. Peroxisome dynamics are sensitive to changes in intracellular redox state induced 
by BSO. 
3. Despite the close peroxisome-mitochondria relationship, mitochondria-derived 
ROS are unlikely to induce changes of the peroxisomal compartment. Among the 
inhibitors tested, only rotenone had a prominent effect on peroxisome elongation, 
however, this effect is due to a microtubule-depolymerizing activity of rotenone. 
4. The in vivo effects of rotenone have to be interpreted with care (e.g. in animal 
models of Parkinson’s disease). 
5. ROS can alter the dynamics of the peroxisomal compartment, but have to come 
from specific locations (e.g. the cytosol) within the cell. 
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Outlook  
 
 Future studies will include in vivo experiments (life cell imaging) using confocal 
microscopy with the purpose to examine and evaluate peroxisome motility along 
microtubules in cells treated with rotenone. Furthermore it will be interesting to examine 
if the stressors induce an up-regulation of Pex11 isoforms as Pex11 proteins are known to 
regulate peroxisome abundance.  
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VI. SCIENTIFIC PRESENTATIONS 
 
The results of this work have been presented and discussed in laboratory seminars of the 
Centre for Cell Biology at the University of Aveiro. 
 
Publications resulting from this work 
Delille, H., N. Bonekamp, S. Pinho, M. Schrader: Hypertubulation of peroxisomes by 
multiple stimuli. 2009/10 (manuscript in preparation, experimental part finished) 
 
Pinho, S., N. Bonekamp, M. G. Lazaro, J. Jordan, M. Schrader: Effect of Rotenone on 
peroxisome dynamics and motility. 2009/10 (manuscript in preparation, experiments 
ongoing; authors are subject of change) 
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